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ABSTRACT 
With advances in high-throughput technologies and next-generation sequencing, the 
amount of genomic and proteomic data is dramatically increasing in the post-genomic 
era. One of the biggest challenges that has arisen is the connection of sequences to 
their activities and the understanding of their cellular functions and interactions. In this 
dissertation, I present three different strategies for mining, predicting and visualizing 
biological functions. 
In the first part, I present the COMputational Bridges to Experiments (COMBREX) 
project, which facilitates the functional annotation of microbial proteins by leveraging the 
power of scientific community. The goal is to bring computational biologists and 
biochemists together to expand our knowledge. A database-driven web portal has been 
built to serve as a hub for the community. Predicted annotations will be deposited into 
the database and the recommendation system will guide biologists to the predictions 
whose experimental validation will be more beneficial to our knowledge of microbial 
 vii 
proteins. In addition, by taking advantage of the rich content, we develop a web service 
to help community members enrich their genome annotations.  
In the second part, I focus on identifying the genes for enzyme activities that lack genetic 
details in the major biological databases. Protein sequences are unknown for about one-
third of the characterized enzyme activities listed in the EC system, the so-called orphan 
enzymes. Our approach considers the similarities between enzyme activities, enabling 
us to deal with broad types of orphan enzymes in eukaryotes. I apply our framework to 
human orphan enzymes and show that we can successfully fill the knowledge gaps in 
the human metabolic network. 
In the last part, I construct a platform for visually analyzing the eco-system level 
metabolic network. Most microbes live in a multiple-species environment. The underlying 
nutrient exchange can be seen as a dynamic eco-system level metabolic network. The 
complexity of the network poses new visualization challenges. Using the data predicted 
by Computation Of Microbial Ecosystems in Time and Space (COMETS), I demonstrate 
that our platform is a powerful tool for investigating the interactions of the microbial 
community. We apply it to the exploration of a simulated microbial eco-system in the 
human gut. The result reflects both known knowledge and novel mutualistic interactions, 
such as the nutrients exchanges between E. coli, C. difficile and L. acidophilus. 
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Chapter 1. Introduction 
Innovations in next-generation sequencing technology have produced a tremendous 
amount of genetic data for the scientific community. Presently, the cost of sequencing a 
human genome is approximately the same as the cost of a sophisticated medical exam. 
After the Human Genome Project completed the first draft of the human genome, the 
scientific community has continued to digitize the genomes of organisms. However, the 
sequenced genome is still not enough to answer the fundamental question: how does 
life work? The central dogma describes the flow of information from DNA to RNA and 
finally to the protein. This concept still holds in today’s post-genome era. Therefore next 
following questions are about where the genes are, what their gene products are, and 
how they interact with each other to create life.   
Parts of these questions would presumably be possible to answer by performing genetic 
and biochemical experiments. However, traditional experiments are usually time-
consuming and labor-intensive, and current technologies are not capable of exhaustively 
characterizing every newly identified gene from every sequenced genome. Innovation in 
the IT industry gives us an opportunity to overcome this obstacle. Computing power has 
increased by a trillion-fold increases over the past six decades(1) and several algorithms 
and computational approaches have been developed to help biologists decipher the 
secret of life. For instance, BLAST, one of the most popular sequence alignment tools, is 
routinely used by scientists around the world to search for similar genes or proteins from 
among the huge gene and protein repositories. In this dissertation, I present three 
different strategies to mine, predict and visualize the cellular functions of proteins. 
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In the first chapter, I introduce a crowdsourcing project, COMputational Bridges to 
Experiments (COMBREX), and its web portal. This project aims to enrich scientific 
knowledge of microbial proteins by using a community-based approach. New 
technologies have created a wealth of genome data, but two major issues with these 
data are the quality and completeness of genome annotations. Most of the microbial 
proteins haven’t yet been experimentally characterized and are annotated with predicted 
functions from the automatic annotation pipeline, and some even have no known 
function. COMBREX tries to address this issue by bringing computational biologists and 
experimental biologists together in an open platform. We build the COMBREX database 
to host the proteins of sequenced microbes and their annotations. The database will 
receive experimental results from experimental biologists, computational predictions 
from computational biologists and the existing knowledge collected from the major 
biological databases. The large and highly informative collection of microbial protein data 
gives us an opportunity to ‘mine’ the protein universe. Resources for performing 
biochemical experiment are limited; therefore to gain the maximum knowledge from 
each protein-characterizing experiment, we develop a recommendation system based 
on the concept of active learning to provide suggestions to experimental biologists for 
the most valuable targets. In addition, we also use the rich information hosted in the 
COMBREX database to help other community members to explore their data.  
COMBREX uses community efforts to mine large-scale databases in order to determine 
the functions of microbial proteins. The project is focused on the problem that many 
proteins do not have proper annotations, and aims to identify the functions of those 
proteins, experimentally or computationally. However, the problem also exists in another 
way: many of the well-characterized biochemical functions do not have corresponding 
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genes or proteins. One example of this type of problem is the knowledge gap between 
enzyme activities and their genetic information in enzymology. Biochemists have been 
studying enzymes and their activities for several decades; however, surprisingly, 
approximately one third of the characterized enzyme activities included in the EC system 
have no associated sequences that can be found in the major genes or proteins archives. 
We have named these ‘orphan’ enzymes. In the second part of this dissertation, we 
address the issue of orphan enzymes in humans and build a computational framework to 
predict candidate genes for the orphan enzyme. Our prediction framework determines 
the candidate genes based on the evidence network, which incorporates the properties 
of biochemical activities. The likelihood of each candidate gene is assessed by a 
supervised learning model. By using human orphan enzymes as examples, we show 
that our framework is capable of helping to fill the knowledge gap and to complete the 
annotation of the genome. 
Previously, we aimed to connect proteins to their cellular functions from two different 
angles: either from the protein perspective or from the enzyme activity perspective. 
Proteins do not work alone; they interact with each other and form complex interaction 
networks in living organisms. Similarly, an organism does not live alone but interacts 
with the outside environment (e.g., taking nutrition) or with other organisms (e.g., 
symbiosis). In the last part of the dissertation, we present a visual analysis platform for 
exploring and mining the complex eco-system level metabolic network. A genome-scale 
metabolic network is a mathematical representation of a living organism. Although a 
metabolic network has been simplified by only taking into account metabolism and 
omitting other factors, such as transcriptional regulation, the resulting genome-scale 
network may still be huge and complex due to the complexity and sophistication of life. 
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When building an in silico microbial community that comprises multiple organisms, the 
metabolic network behind the eco-system is even much larger and poses new 
visualization challenges. Here, we develop a new layout algorithm and several 
visualization tools to emphasize the biological meaningful subnetwork on the complex 
network. Using the data predicted by Computation Of Microbial Ecosystems in Time and 
Space (COMETS) as examples, I demonstrate that our visual analysis can efficiently 
help biologists investigate and understand microbial community interactions. 
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Chapter 2. COMBREX – a web platform to bridge the gap between computational 
and experimental biologists 
2.1 Introduction 
The semiconductor industry generally follows Moore’s well-known law - computer power 
is doubled approximately every two years. DNA sequencing costs, in contrast, have 
surpassed this principle since 2008(2). There have been tremendous changes in the 
area of genome research thanks to next-generation sequencing technologies, and not 
only in terms of cost. Unlike the Human Genome Project that took 13 years to complete, 
new technologies claim to be able to sequence 18,000 human genomes per year(3). 
With this, soon, the “$1,000 genome” will not be simply a catchphrase, but a reality. 
Other biological researchers may not be so lucky. Biochemists, for one, do not share the 
same joy from technology innovation. Although the development of high-throughput 
methods allow researchers to quickly conduct hundreds to thousands of tests in a single 
experiment, the majority of biochemical study still heavily relies on labor-intensive and 
time-consuming laboratory work. To date, there is still no high-throughput technology 
that could experimentally reveal the functions of all genes in sequenced genome. 
The imbalance between genetic research and biochemical research forms a huge 
knowledge gap. The wealth of genomic data pumped out by new sequencing 
technologies offers much potential for biomedical research. Sequence data are usually 
feed into an automatic annotation pipeline to identify genes and their functions, and then 
are deposited into public repositories for the benefit of the whole community. 
Computational approaches, especially sequence similarity-based methods, have a 
crucial role to play in annotating genomes. The prediction algorithms commonly attempt 
6 
 
to leverage the knowledge of well-characterized genes - usually representing a relatively 
small proportion of genes in a repository - to predict the function of newly identified 
genes in a freshly sequenced genome. Most of the computational models assign 
functions to genes with a confidence score to indicate the likelihood that a gene is 
associated with a specific function. This complete evidence (algorithm, score, source 
gene etc.), however, tends to be omitted when the annotated data are open to public. 
The loss of evidence makes most of the public annotation nontransparent. Moreover, an 
estimation from selected genomes shows that, at best, approximately 70% of genes in 
selected genomes have experimentally validated or computationally predicted 
annotations(4).  Presently, there is the challenge being faced of the remaining 30% of 
genes which functions are completely unknown. 
The computationally predicted annotations, even those made by state-of-the-art 
algorithms, are error-prone and have quite a bit of room for improvement. First, the 
quality of prediction is far from prefect. Second, the algorithms build model based on the 
small fraction of well-characterized genes that exist, only covering a minimal set of 
functions. This could be a potential bias when exploring the protein universe. The 
majority of annotation pipelines are backed by similarity-based approaches. The function 
is propagated from a validated gene to its homologs. One can imagine that a gene which 
has a unique structure and is not similar to any other genes in the database may never 
been assigned a correct function by the computational annotation pipeline. As well, the 
publically available resources frequently used by the biology community may contain 
errors. Babbitt et al. brought up the issue of misannotations in public databases(5). 
Several systematic problems are responsible for causing the high level of errors seen in 
the public sequence archives. It would be relatively expensive to fix those errors as the 
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detailed evidence (to support the annotation) is not retained in the system. The ultimate 
solution to accurately characterize a protein would be through performing the necessary 
biochemical experiment. Without access to future high-throughput technology with the 
capability to process hundreds to thousands of tests in one single experiment, dedicated 
laboratory experiments to test certain selected functions of a gene or protein are still the 
most effective (while also expensive) way available 
To this end, here COMBREX (COMputational Bridges to Experiments) is introduced, a 
web portal and community based project. COMBREX aims to build a strong community 
by bringing computational biologists and experimental biologists together and share their 
work on COMBREX.  In the following section, an overview of the COMBREX web portal 
and the impact of the COMBREX project starting from the first phase are provided.  
2.2 Architecture and system design 
To serve the COMBREX community, a content-rich, database-driven web site was built. 
The entire web portal includes two parts: a user database containing user information 
and a biological database consisting of annotations contributed by the research 
community or collected from major annotation archives. The user database was 
designed and maintained by a professional team and is beyond the scope of this 
dissertation. Here, the focus will be on the biological database and its scientific role. 
2.2.1 Database schema 
The biological database is the heart of the COMBREX web portal. It maintains microbial 
protein knowledge from the community and public data repositories. A simple ER 
diagram describing the relationship between the key elements in the database is shown 
in the Figure 2-1. 
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Figure 2-1. ER relationship diagram of the COMBREX biological database  
 
The center of the ER diagram is `Protein`. A protein may associate with several 
annotations assigned by different researchers. Annotations can be categorized into two 
groups: experimentally validated functions (`Function` in the diagram) and predicted 
functions (‘Predicted Functions’ in the diagram). Ideally, each annotation should 
include a `Source` or a `Team` which explicitly indicates the origin of the record as well 
as other supporting information and/or a confidence score. If the origin is not clear 
(which is the most common case for the annotations retrieved from the protein archives), 
then the next most readily available information such as the name of the source 
database will be used. A protein may have several identifiers employed by different 
databases for various purposes. COMBREX tracks the common biological identifiers for 
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each protein and creates links from COMBREX to other major data archives like NCBI 
and UniProt. 
Proteins sharing similar properties can be grouped together into families or clusters. 
Those high level and abstract organizations are able to help researchers study and 
understand protein function. In COMBREX, we take advantage of the NCBI Protein 
Cluster database (ProtClustDB) (6), a collection of protein clusters that organize proteins 
based on sequence similarity and function (this will be discussed in more detail in the 
‘Data integration’ section). In addition, as protein domains play a major role in protein 
functions, and so COMBREX uses the Conserved Domain Database (CDD)(7) to 
support protein domain knowledge for the community. It should be noted that the ER 
diagram in Figure 2-1 only captures the relationships between the major objects in the 
database. A complete database schema is available in Appendix A. 
2.2.2 Data integration 
As a hub of the project, the COMBREX web portal aims to provide a wealth of microbial 
knowledge to the entire research community. In addition to the in-house data set, data 
were also collected from the major public archives. By integrating these related 
biological records, it is possible to generate a summary for each microbial protein and let 
a community member examine the annotations originating from different sources. 
2.2.2.1 Data from the major biological database 
Biological data are heterogeneous. They are created by different organizations for a 
number of purposes and stored in different data archives using various data-
management systems. Commonly, one unique biological object may have several 
different identifiers used in several places. Based on the complexity of life, the 
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relationship between biological entities stored in the same or different databases may 
not always be understood through simple one-to-one mapping; sometimes there are 
one-to-many or even many-to-many relationship. Mapping one dataset against another 
occasionally produces imperfect results. In COMBREX, introducing a new identification 
system for genes and/or proteins to the biology community is avoided. Instead, 
EntrezGeneID, the unique identifier assigned to each gene record in the NCBI 
EntrezGene Database, was chosen as the primary identifier in the database. All external 
data are integrated into COMBREX through id mapping tables provided by NCBI. In the 
case of no corresponding EntrezGeneID, COMBREX assigns a temporal identifier for 
the specific object until an official EntrezGeneID has been created by NCBI. Below is a 
list of external data sources. 
 NCBI EntrezGene 
 NCBI Protein Cluster Database 
 NCBI Taxonomy Database 
 UniProt 
 CDD 
 RefSeq Database 
 Pfam 
 BRENDA 
 TargetDB 
 KEGG Pathway 
 Gene Ontology 
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2.2.2.2 Gold standard database 
Having a set of genes where the functions are already experimentally validated is critical 
for the entire research community. Computational biologists can build models on top of 
those validated genes and therefore suggest functions for other uncharacterized genes. 
In addition, analyzing the distribution of those genes and being aware of the current 
trends in biology will help scientists identify knowledge gaps and avoid bias in feature 
research. In collaboration with UniProt, NCBI and JCVI, work has begun compiling a 
comprehensive set of genes with sequences and biochemical functions determined via 
strong experimental evidence, dubbed the Gold Standard Database (GSDB). 
The workflow of building the GSDB is illustrated in Figure 2-2. Initially potential 
experimentally validated genes from the public curated databases such as ReBase, 
CharProtDB and SwissProt were searched for. A community member can also nominate 
a gene as a putatively validated gene on COMBREX web portal. All candidate genes 
must have a proper UniProt Accession number, in order to pursue data curation. If they 
do not, for any reasons, the information for those genes without UniProt Accession 
number will be sent to UniProt to be held until entries are created and UniProtKB 
accession numbers are formally issued. Genes in the GSDB queue will be part of green 
gene (presumably experimentally validated) on the COMBREX website. Volunteers will 
pick up genes from the queue and manually examine if a gene and its annotation meet 
the GSDB criteria. Basically, a curator will check if there is evidence in the literature to 
support the association between a candidate gene and its annotations. One common 
issue is that the biochemical tests, the results of which form a component of the 
experimental evidence, were performed on a bacteria strain different from the strain 
which the candidate gene belongs to. Sometimes the subtle changes in sequences 
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between the candidate genes and the actual test genes may have a big impact on their 
biochemical function. The curator will have to identify all such kinds of annotation issues 
and decide if a candidate can be moved into the GSDB or whether more evidence is 
required to do so. Another important criterion is that the experimentally validated 
annotations must have traceable evidences. Namely the experiment to determine protein 
function must be a published work or fully documented in a public database. The aim is 
to ensure sure that every gene in the GSDB would have tight and transparent linkages 
between their sequences and their validated annotations.  
Data curation is a slow process as only a few elements in the curation workflow can be 
automated. Also, it is a necessity that a well-trained curator needs prior knowledge in 
biology/biochemistry. During the data curation process, a curator reads the relevant 
research articles, verifies the annotations and makes the final decision, and this all has 
to be done manually. It is estimated there could be more than 50,000 genes with 
experimentally determined functions among the entire protein universe. Right now, the 
GSDB is still very small (13,665 in queue and 164 accepted) but continues to grow. The 
majority of genes in the GSDB are in the queue and need to be reviewed by a curator. 
There is hope a community effort can help complete the GSDB. Although the data 
processing workflow of the GSDB is independent to the COMBREX web portal, the 
GSDB is tightly integrated with the annotations in COMBREX. All genes (in queue or that 
have been approved) are accessible via the COMBREX web portal. The approved 
genes are labeled as ‘Gold’ in the system. The remaining genes (uncurated) will be part 
of the green genes in COMBREX. In addition, a user can nominate a protein for GSDB 
candidacy via a simple web submission form on the portal. A COMBREX community 
member will review if all the required information was supplied along with submission. 
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Qualified genes will be placed into the GSDB queue for further examination in the GSDB 
curation pipeline. 
Genes nominated by 
the community or 
collected from REBASE, 
CharProtDB etc
Has a 
UniProt 
Accession
Submit to 
UniProtKB
Put into curation 
queue
Exam by curators
Meet 
criteria
Add to GSDB
Require further 
research
Yes
No
Yes
No
 
Figure 2-2. Data curation workflow of GSDB 
2.2.2.3 Data submitted by COMBREX community members 
In addition to the data coming from the public data archives, COMBREX encourages 
every community member to contribute knowledge whether the data are from 
experimental tests, generated by computational methods, from domain knowledge or 
taken from the literature. Data curation is a labor-intensive work and there is no doubt 
that many of the gene/protein annotations are still imperfect. However it is nearly 
impossible to improve the annotations of the entire protein universe with a single team of 
few people. It is hoped the community participation will speed up the whole process and 
come up with high quality annotated genomes. 
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There are four ways to participate in the COMBREX project. The simplest action is to 
‘Post Comment’. A user can leave a message containing the information which other 
researchers may find useful via the web portal (Figure 2-3). The submitted comments 
will be available on the gene detail page once they pass basic review. This method 
provides the highest flexibility for sharing any valuable knowledge in free text. However, 
it is highly recommended that scientists provide knowledge in a structured format (if it is 
desirable). At the initial stage of the COMBREX project, three simple data formats to 
support different types of the annotation data were proposed and computational and 
experimental communities can submit their functional annotations to COMBREX using 
one of them. More details on those formats will be described in the following section. 
 
Figure 2-3. The web Interface for a user to add a comment 
As mentioned in the GSDB section, a researcher can nominate a gene for inclusion in 
the GSDB via the web portal. As a consequence of limit manpower, it wasn’t possible to 
exhaustively manually survey genes in the database and identify all putative GSDB 
candidates. Therefore, many of the experimentally characterized genes may not be 
15 
 
discerned by the GSDB. Again, with COMBREX, the community effort to complete the 
GSDB is imperative. 
Experimental biologists have a special role in the COMBREX project. More specifically, 
they can submit a grant application for experimental validation. COMBREX would offer 
small grants (typically in the range of $5,000 to $10,000) to support the experimental 
tests. A grant application can be submitted online through the web portal and would be 
reviewed by the COMBREX committee. The number of available grants would be limited. 
In order to maximize the value of each COMBREX grant, a grant targeting a protein that 
has a larger impact submitted by a laboratory which already has experience in the 
proposed assays would be favored. 
2.2.3 Central repository for computational predictions 
Most journals enforce a data availability policy that necessitates the biological data sets 
(for example, protein and DNA sequences, high-throughput omic data etc.) described in 
a manuscript must be publicly available. A number of journals, such as Science, have 
stricter rules specifying that certain scientific data must be deposited into an approved 
database. Other journals may provide a set of recommended repositories which are 
community-endorsed and publically accessible. Usually a proper data id/accession 
number (can be used to retrieve the data recorder from the repository) must be provided 
in the manuscript. For instance, UniProt is one of the well-accepted repositories for 
protein sequence data. An author who wants to publish an article will commonly submit 
the protein sequences used to reach the conclusions into UniProt first and then include 
the corresponding UniProt accession numbers in the manuscript. For most biological 
data, there is a place to go. However, there is no established public repository which is 
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specific to computationally predicted annotations. They are usually announced on the 
author’s website or as part of the supplementary materials of manuscript. The number of 
predictions generated by a single method would be in the range between a couple 
hundred to more than thousands. Unfortunately, except the ones explicitly emphasized 
in the manuscript, the visibility of those predicted annotations is pretty low. Shortly 
thereafter, those newly predicted annotations lose popularity and ultimately, impact on 
the community. 
Being a public repository of predicted annotations for computational biologists is one of 
the goals with COMBREX. One can deposit his/her functional predictions into 
COMBREX and this new knowledge will be exposed to the entire community for others 
to review and provide comments and suggestions. Experimental biologists and 
computational biologists can share knowledge and exchange information in the same 
place. It would also potentially increase the visibility of new computational predictions. 
With this, one algorithm may be suitable for certain types of proteins but has poor 
performance with others – it would be difficult to make a fair comparison between 
computational algorithms. On COMBREX, it was not intended to build a global 
benchmark for computational algorithms, but instead, provides an open platform for 
scientists. All supporting evidence would be public to help community members evaluate 
annotations. 
One problem that exists is that there is no standard data format for computationally 
predicted annotations. To help computational biologists submit their data into 
COMBREX, we initial three different types of data formats for the gene/protein 
annotations generated by computational algorithms. The first is the result of a set of 
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predicted functions for a set of individual genes. Basically, the algorithm able to generate 
this type of output aims to provide a direct association between genes and functions. 
Some algorithms may provide predicted functions in plain text; others may use a 
controlled vocabulary such as GO Terms or EC Numbers. To adopt a broad range of 
data formats used by the computational biology community, it is encouraged, but not 
required, for a user to supply predictions in GO or EC in addition to the original free text 
predictions. 
The second common type of data is the predicted linkages between genes or proteins. 
Depending on the algorithms utilized, the linkage may represent a functional association, 
causal relationship, or something else altogether. The data need to be formatted as an 
edge list, commonly used to represent a network. A user would be able to supply more 
detailed information, such as the direction and even an annotation to each linkage by 
using this format. 
The last data format is suitable for predicting protein/gene families or groups. There are 
no strict limits. Each group contains a set of genes or proteins. One gene/protein can be 
a member of multiple families or groups. One can just predict the correlation between 
genes/proteins without any functional assignment. Another option is that each group can 
be associated with a function and the function can be propagated from a group to its 
group members.  
To meet COMBREX data standards, each submission must supply at least one 
reference pointing to a publication describing the method used for obtaining the 
particular prediction. In addition, it is recommended, but not required, that every 
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prediction also comes with a confidence score that is generally reported by the 
prediction algorithm. The details of the file format are in Appendix B. 
Different prediction methods require different input data and make predictions based on 
different statistical models. Therefore a direct comparison of the confidence scores 
calculated by different algorithms is more or less an apples-to-oranges comparison. 
However, the confidence score should be one of the most important forms of information 
when looking at predictions. Ideally, other biologists would evaluate the correctness of 
each annotation made by the computational algorithm. 
2.2.3.1 COMBREX color code 
COMBREX introduces a simple color code system to indicate the annotation status of 
genes and protein clusters. Four unique colored symbols were used as visual cues to 
reflect the latest experimental validation status of genes. The color is updated every time 
new data is added to the system. For each gene in COMBREX, it will receive one of 
following colored symbols 
Gold Circle (Gold): indicates that the gene is in the GSDB. In particular, the protein has 
an experimentally validated annotation and the DNA sequence for the exact protein has 
been determined. All information is reported in published articles or can be found in a 
public data repository. 
Green Circle (Green): portion of the genes in this category are genes in the GSDB 
queue. They are uncurated but have the potential to become ‘Gold’. Those genes will be 
‘upgraded’ to ‘Gold’ if they meet the GSDB criteria or will be downgraded to ‘Blue’ if 
experimental evidence is not strong enough to support the annotation. The remainders 
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of these genes that are not in the GSDB queue are genes which either have not been 
placed in the GSDB curation pipeline yet or still lack the required information for ‘Gold’ 
status.  
Blue Square (Blue): indicates a gene has at latest one predicted molecular function in 
the system. However, it also suggests that it has not been experimentally validated or 
the genes’ experimental validation status has yet to be established in COMBREX. Some 
of the ‘Blue’ genes could be former genes from the in GSDB queue that were 
downgraded. 
Black Diamond (Black): genes are not associated with any known function; or genes 
only have a nonspecific annotation such as ‘hypothetical protein’, ‘putative protein’ or 
‘predicted protein’ 
In addition to genes, each cluster will also receive a colored symbol which represents 
the experimental validation status of its members at a glance. While a protein cluster is a 
set of proteins sharing certain common properties (for example, sequence similarity), it is 
impossible to actually determine the biochemical function of a cluster. Therefore there 
would be no ‘Gold’ cluster; a cluster can only be either ‘Green’, ‘Blue’, or ‘Black’ 
Green Circle (Green) - indicates the cluster contains at least one experimentally 
validated (Gold gene) or presumably validated (Green gene) members. Other gene 
members may remain blue if there is no experimental evidence, though no member is 
‘Black’. 
Blue Square (Blue) – indicates that the cluster has no ‘Gold’ and ‘Green’ members but 
contains one or more genes with predicted annotations. 
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Black Diamond (Black) – all of the gene members of this cluster have unknown functions 
or unspecific prediction of molecular function. 
The detailed distribution of genes status in each type of clusters is listed in Table 2-1. It 
is to be noted that a Gold or Blue cluster may possibly have a member without any 
meaningful annotation from anywhere else except COMBREX. The COMBREX data 
integration/annotation pipeline will conceptually transfer the color status as well as the 
annotation from a gene member to the cluster. The status of a cluster is determined by 
its most informative member (Gold > Green> Blue > Black) and the other members of 
the same cluster may inherit that status from the cluster. Inherited status overrides the 
original gene status only if the original gene status is ‘Black’. In such a case, COMBREX 
suggests an additional annotation (the one from the cluster) to this ‘Black’ gene. For 
instance, gene NT01EI_3287 (GeneID:7961118)  was annotated as a ‘hypothetical 
protein’ in COMBREX. This gene is not associated with any specific molecular function; 
no other informative annotation is available at the time of building the database. 
However, this gene received a ‘Blue’ status because it is a member of ‘Green’ cluster 
PRK10198: formate hydrogenlyase regulatory protein HycA. As genes in the same 
cluster have a high degree of sequence similarity, COMBREX assumes this unknown 
gene may perform a similar function as other genes in the same cluster, and the reason 
for this cluster being green is that there is a ‘Green’ gene hycA (GeneID: 947193) inside. 
Table 2-1. The number of genes in each annotation status in COMBREX. 
Cluster Gene Number 
Green Gold 263 
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Green 6715 
Blue 507185 
Blue Blue 1744064 
Black Black 509407 
2.2.3.2 Traceable evidence 
COMBREX aims to provide traceable evidence for every record of functional annotations, 
which unfortunately, were not usually maintained in most biological databases. A 
number of databases provide a time-series data log for each data entry. For example 
UniProt has Entry History that basically logs the evolution of a specific data entry (for 
instance a protein record). However, this is primary focused on changes of the records. 
For various types of information, for instance, the method (either a computational 
method or an experiment) used to provide the annotation could be omitted. 
It is clear that for the genes with an experimentally validated function, the annotated 
function should be linked to a public document containing the experimental details. For 
the genes with a predicted function, traceable evidence refers to the details of the 
methods used to make such an annotation. Ideally, the details would include, but are not 
limit to, the computational algorithm and the confidence level. If the predicted function is 
transferred from other genes (whether it has been experimentally characterized or not), 
then the ‘origin’ of the annotation should also be included as evidence. Such detailed 
information is important for other researches to access the accuracy of a particular 
annotation. In addition, the annotation-transfer cascade lets the community knows how a 
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specific molecular function spread around the whole protein universe. One is able to 
easily fix a misannotation if there is an error or update the existing annotation once a 
protein function was validated. Although this knowledge is vital, in practice, few 
biological databases explicitly provide it. Except the data submitted by COMBREX 
community members, the annotations integrated from the major public archives do not 
have traceable evidence. An approach must be found to fill in this missing information. 
Based on the original evidence (of the non-validated annotations) not always being 
available, in COMBREX, alternative traceable evidence for all genes in the system is 
supplied. Thanks to the GSDB which hosts a set of genes with solid data, a direct 
comparison between genes without experimental evidence with the well characterized 
genes (Gold and Green genes, for example) is performed to enable linkage between the 
genes (Blue genes) with predicted annotations and their possible source. Although the 
source genes suggested by this alternative traceable evidence may not match those 
used by the original method, this sequence similarity-based assessment would yield a 
rough estimation of confidence. In addition, the same framework is employed to make 
links between all uncharacterized genes (Black gene). These linkages (to a gene with an 
experimentally determined function) would serve as a supporting prediction for those 
genes without any clues. 
2.3 System features 
2.3.1 Web Interface 
The COMBREX web portal is designed to allow users to easily find interesting microbial 
genes and evaluate their annotations. In order to locate the proper genes from the huge 
collections of knowledge COMBREX has, the system offers flexible search options to 
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assist biologists in retrieving the information they need. Figure 2-4 shows the search 
interface on the COMBREX web portal. A user can search for genes and protein clusters 
by providing keywords which describe the function of interest, by providing the standard 
identifier of a particular biological entity (e.g. an EntrezGene ID or an UniProt Accession) 
or by providing a controlled vocabulary term, like GO term or EC number. The more 
specific the information input into the search, the easier it is to acquire precise data from 
the database. For instance, if a user is interested in the annotations of a particular gene, 
then performing a search by using the EntrezGene ID or RefSeq accession is the 
preferred strategy. 
 
Figure 2-4. The search interface on the COMBREX web portal 
Keywords are the easiest way to search for data from the COMBREX database. The 
search result can be more focused by using the advanced search function, allowing a 
user to more easily find genes of interest. Several search filters are provided. For 
instance, users can restrict the search for proteins in certain species, for proteins 
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associated with certain phenotypes, for proteins with a particular functional status or for 
proteins with certain properties such as ‘cloned by PSI’ or ‘with solved structures in PDB’. 
By default, all search results are organized by Protein Cluster; even if there is only one 
gene meeting the search criteria. This unique data representation allows users to 
explore other relevant and important genes which are not included in the original search. 
Figure 2-5 shows a typical search result. In this example, a search with the keyword 
‘GTPAse’ was performed. The search result returned 433 protein clusters and 334 
individual proteins not assigned to a cluster. It is worth noting that if a user searches for 
a specific gene in the database, COMBREX will return that particular gene listed 
underneath a protein cluster which it belongs to. The default ranking is based on the 
initial phase of the COMBREX Recommendation System. Generally speaking, its 
objective is to guide experimental biologists towards identifying experimental targets that 
are more ‘important’ for understanding the protein universe (more details will be covered 
in the next section). Additionally, a user can reorder the search results to suit a particular 
need. The results show the annotation status of protein clusters and their members at a 
glance. The number of genes in each functional category (Gold, Green, Blue and Black) 
will be shown next the cluster. To save space, only the particular genes which meet the 
search criteria and the COMBREX recommended genes will be displayed. A user can 
open the detailed ‘Gene Page’ or ‘Protein Cluster Page’ by clicking on the gene or 
protein cluster. A full list of protein members for each Protein Cluster as well as other 
supporting information, like the phylogenetic information and the sequence relationship 
within the cluster, will be shown on the ‘Protein Cluster Page’. Similar, the full details and 
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annotations of each gene will be provided on the ‘Gene Page’ of each gene.
 
Figure 2-5. A sample search result. In this example we search for keyword ‘GTPase’ in the 
COMBREX database. 
2.3.2 Recommendation system 
Hundreds of thousands of proteins with functional annotations are found in public 
repositories. Most are not experimentally validated and need testing by biologists. 
However, wet lab experiments to verify the biological role of a protein are usually costly, 
and the experiments themselves can take from a couple of months to many years. 
Experiments performed by a well-trained laboratory may be able to speed up the 
process. With COMBREX, another systematic approach is taken: a recommendation 
system directs experimental biologists to the most valuable protein with the larges 
impact on the entire protein universe. 
The recommendation system is based on the concept of active learning. The initial 
implementation is a rule-based system composed of a set of rules suggested by experts 
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in the community. A biologist first specifies his/her search criteria based on his/her own 
interesting. For instance, a user can narrow down the search space to a biochemical 
function which he/she is interested in, to an organism which he/she is familiar with, or 
both. COMBREX will first retrieve all proteins which match the search criteria and then 
list the results ordered by their ‘importance’. 
‘Importance’ is a very board term, and to different scientific communities, the term will 
have very different meanings. With COMBREX, the recommendation system seeks to 
suggest the genes that experimental validation result would potentially have the most 
significant impact in terms of function propagation to other uncharacterized genes in 
each functional category biologists are interested in. The current system is a prototype 
which incorporates several criteria to identify the ‘important’ genes in the database. It 
includes 
1. The functional status of genes. Each gene in COMBREX is associated with a 
functional status (Gold, Green, Blue and Black) which, in general, is determined by the 
quality of the annotation. Putting effort into well-characterized genes gains little new 
information for the community and performing experiments on proteins without any 
predicted function may come with more challenges for biologists as it would be more 
difficult to obtain a testable sample.  A robust candidate for experimental validation 
would be a gene with testable annotation(s) without any experimental evidence.  
2. The size of the protein family. Proteins of the same family are closely related and may 
share the same function on a certain level. Experimental findings will potentially be 
beneficial to learning more about other proteins in the same family. For example, once a 
biochemical function was assigned to a protein, the protein family containing it may 
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acquire the newly assigned function and other members of the same family may inherit 
the functional annotation. Therefore in COMBREX, a protein belonging to a large family 
will be more important than a protein belonging to a small family.  
3. The genome of origin. Two organisms- Escherichia coli K-12 MG1655 and 
Helicobacter pylori 26695-were chosen to be the top-most priority. Escherichia coli K-12 
MG 1655 represents E. coli, one of the most well-studied living organisms. Many E coli 
genes have already been examined by researchers. COMBREX selected E. coli in order 
to help the community complete the understanding of the whole genome and 
biochemical activities in a single organism. The later one, H. pylori infects approximately 
two-thirds of people globally, so it is important to human health and disease.  Further, H. 
pylori infection is associated to the development of peptic ulcers and even gastric cancer. 
H. pylori serves as an evolutionally distant and poorly studied (but not completely 
unknown) model organism in COMBREX. Genes in these two selected organisms are 
assigned higher priority. 
4. The position within the cluster. A protein family may contain 10 to hundreds of 
proteins. Not all members share the same degree of similarity, and within the same 
protein family, some members may be slightly apart from the others. COMBREX 
recommends genes which will best represent a protein family so the suggested genes 
can serve as a proxy of a family which the protein belongs to and reduce the ambiguity 
and errors in the follow-on functional prediction. 
2.5 Application 
COMBREX is the first database with the objective to provide fully traceable evidence 
and attempting to unlock the power of the research community to expand the knowledge 
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of microbial proteins. To truly unleash the potential of COMBREX, a web service named 
COMBLAST was developed to collaborate with other community members in order to 
solve the data annotation issues. Here two examples of how COMBREX enriches 
genome annotations are described. 
2.5.1 Deep sequencing of the oral microbiome reveals signatures of periodontal disease 
Oral microbes in human form a complex community and play an important role in overall 
health. In this collaboration project, combining the metagenome sequencing data of the 
whole oral microbiome community and computational approaches to study the oral 
microbial ecosystem in periodontal disease takes place. With this, it is possible to 
assemble a TM7 genome, an unculturable organism that is commonly found in human 
oral flora. Genes found in this improved TM7 genome assembly but not in the original 
TM7 reference genome (NCBI accession NZ_ABBV00000000) are considered novel 
genes. The resulting 703 novel genes are then subjected to annotation using COMBREX. 
Those 703 novel genes were mapped against all microbial proteins in COMBREX for 
functional annotation using BLASTp with the following threshold: (1) e-value <= 1e-5 (2) 
coverage of the subject sequence >=80%. At the end 161 novel genes were received 
annotated from COMBREX. The full list of those 161 novel genes and their annotations 
are listed in Appendix C. 
The annotation revealed 10 ribosomal protein genes as well as other housekeeping 
genes which should be conserved in TM7 genome but are omitted in the reference 
genome. It suggested that the new assembly make available more insights into this 
mystic organism. In addition, several potential virulence genes and two phage proteins 
found in the new assembly may represent events of de novo insertions in the sample. 
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2.5.1 Analysis of thousands of missed genes found in bacterial genomes 
The drop in sequencing costs allows more researches and institutes entry into the 
sequencing and annotation business. However, the annotation methods being used vary 
among teams, thereby resulting in different qualities. A large number of likely genes are 
missing from all kind of the prokaryotic genomes available in the public archives. In this 
collaboration project, 1,474 prokaryotic genomes downloaded from GenBank were re-
analyzed, and COMBREX and the COMBLAST service are used to assess the 
supporting evidence and provide functional annotations to those missing genes. 
The in-house genome annotation pipeline will generate two sets of likely missing genes: 
‘Hypothetical Missed Genes’ and ‘Named Missed Genes’. Named Missed Genes are 
genes which have been omitted from the archives but have a high degree of sequence 
similarity to genes with functional annotations in the NCBI RefSeq database. Other likely 
missing genes which are only similar to genes without a specific function (usually named 
‘hypothetical protein’) are categorized into ‘Hypothetical Missed Genes’. To have better 
understanding of these missing genes, the COMBLAST service was employed to assign 
COMBREX supporting levels to each gene in both categories. The stronger the support 
level is, the more likely the missing gene is a true protein-coding gene. 
First a homology search was performed for missing genes against all genes in 
COMBREX. Next, the supporting level of a candidate was determined by the properties 
and annotation status of its homologs. For example, a candidate would receive a higher 
supporting level if its homologs were present in many organisms. The previous evidence 
would indicate that the candidate gene will probably be more conserved than others, and 
therefore, it will have a higher chance of being a real protein-coding gene, through 
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omitted by other genome annotation pipelines. Based on prior knowledge, a rule-based 
decision support system was compiled for evaluating and annotating the candidate 
missing genes. The details are listed in Table 2-2 
Table 2-2. The criteria for each COMBREX support level. 
COMBREX 
Support Level 
Criteria 
Strong  Can be assigned to a cluster which has more than 50 
members coming from at least 2 different phyla or has 
more than 50 homolog genes in COMBREX 
 Its homolog genes are associated with at least one of 
the following pieces of information: experimentally 
validated annotation, known 3D protein structure, 
presence of purified protein, containing a functional 
domain or EC annotation. 
Fair Does not meet the Strong criteria but 
 can be assigned to a cluster which has at least 5 
members or has 10-50 homolog genes in COMBREX 
Weak The Named Missed Genes which do not fall into the Strong or 
Fair categories but still have significant sequence similarity to at 
least one gene in COMBREX  
Insufficient The remaining Hypothetical Missed Genes which do not fall into 
the Strong or Fair categories but still have at least one homolog 
genes in COMBREX. 
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We identify 13,602 Named Missed Genes and 39,003 Hypothetical Missed Genes from 
1,474 completely sequenced genomes. The COMBREX/COMBLAST analysis yielded 
13,307 (97.83%) Named and 36,127 (92.63%) Hypothetical missed genes with 
COMBREX support level. Figure2-6 shows the detailed result. A full list of missing genes 
with their COMBREX support level and annotation can be downloaded online at 
http://combrex.bu.edu/MissedGenes 
 
Figure 2-6. The number of genes with different level of COMBREX support level 
 
2.5 Conclusions 
The COMBREX project attempts to expend the knowledge of microbial proteins, and 
eventually complete microbial genome annotations, through a crowdsourcing approach. 
In order to provide an open platform for community members to share their knowledge, 
the COMBREX database and its web portal was built. Both computational biologists and 
experimental biologists can work together and provide their insight and knowledge for 
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the whole community. The vast majority of functional annotations in the database are 
determined by computational approaches, which are imperfect and error-prone, and 
have never been experimentally confirmed. Unfortunately, it is nearly impossible to 
experimentally test all microbial proteins with the current technology available. As 
biological experiments are usually time consuming and costly, COMBREX attempts to 
enlarge the impact of each individual experiment by recommending the ‘important’ 
targets to experimental biologists. At the initial phase of the project, two organisms, E. 
coli and H. pylori were selected as proof-of-concept models. With the growth and the 
participation of the community, COMBREX and its web portal will quite possibly greatly 
assist exploration and understanding of the protein universe.  
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Chapter 3. A Systematic approach to identify genes for orphan enzymes 
3.1 Introduction 
New high-throughput and low cost sequencing technologies offer a wealth of 
opportunities to the scientific community. For example, in 2011, our scientific community 
sequenced and annotated the genome at the rate of 1.37 genome per day(8). The 
genome sequence as well as the functional annotations will be deposited into public 
archives such as NCBI, and will soon be open to the public. On the other hand, 
enzymatic processes have been studied by biochemists for many decades. Since 1956, 
the Nomenclature Committee of the International Union of Biochemistry and Molecular 
Biology (NC-IUBMB) has classified more than four thousand enzyme activities in the EC 
system. As of 2014, there are 5,445 entries, including preliminary EC numbers, listed in 
the enzyme nomenclature database(9). Enzymes collected in the EC system had been 
biochemically characterized. Normally their molecular function had been examined in a 
laboratory. Surprisingly, many lack corresponding genetic details in the major protein 
archives. A 2007 study(10) shows that at least 36% of known enzyme activities have no 
representative gene or protein sequence in any organism; specifically, the genetic 
details of approximately one-third of enzymes are still unclear. This represents a huge 
knowledge gap between the biochemical and genetic research. For experimentally 
characterized enzymes that have yet to be associated with a gene and/or a protein, we 
consider them to be orphan enzymes(11). 
Orphan enzymes can be global—the enzyme activity is not associated with any 
sequence in any species—or local—the sequence is only known in certain species. The 
distribution of orphan enzymes is independent of the age of the discovery. Lespinet et al. 
found that even in the post-genomic era, many newly discovered enzymes are still not 
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associated with any sequences(11). Figure 3-1 shows the number of newly created EC 
numbers and the number of new global orphan enzymes each year. The plot 
demonstrates that the number of new global orphan enzymes is highly correlated with 
the number of newly added EC, even in the past ten years. The existence of orphan 
enzymes indicates the disconnection between enzyme characterizing experiments and 
protein annotations. A significant amount of orphan enzymes could be attributed to 
several systematic errors in the major databases. A 2007 survey shows that 20% of 
orphan enzymes are artificial(10). They become orphan because their genetic 
information and molecular function are not coupled in the major data archives. Their 
sequences could be identified, potentially, by mining the literature without performing 
any additional wet-lab tests. A more recent study shows that 270 out of 1,122 putative 
orphan enzymes can be solved via a literature and database search pipeline(12). A deep 
analysis of those resolved orphan enzymes reveals that they exist because of missing 
annotation updates or data labeling errors. The authors point out that the creation of 
those orphan enzymes can be avoided at the system level: for instance, a more 
transparent enzyme annotation workflow to ensure every newly sequenced enzyme is 
properly connected with an enzymatic function. By moving the scientific community 
toward a more standardized and rigid data deposit protocol, we may be able to prevent 
the creation of those systematic “fake”-orphans. However, the majority of orphan 
enzymes (~75%) occur not because of such systematic errors. They are real and require 
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human care. 
 
Figure 3-1. Number of new added EC and new orphan enzyme per year. Data are 
downloaded from ORENZA(13) database.  
We can look at the orphan enzyme problem from another angle. Many of the 
uncharacterized genes in the sequenced genome may contribute to the orphan enzyme 
problem. For instance, according to the COMBREX database, E. coli K-12 MG 1655, 
one of the well-studied organisms, has 2,301 genes, the functions of which have been 
presumably experimentally validated, 1,814 genes with computational predicted 
annotations and 37 uncharacterized genes. Some of those uncharacterized genes could 
be responsible for orphan enzyme activities. The number of uncharacterized genes 
could be much higher in other poorly-studied organisms. The value of the genomic 
information depends on high quality and accurate annotations. Filling the orphan 
enzyme gap would benefit to the community by completing the genome annotations. 
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When a genome was sequenced, soon the new biological knowledge will be added to 
the biology community via the annotation pipeline. The presence of the orphan enzyme 
introduces a big black hole into the annotation system, i.e., the genes or proteins 
associated with orphan enzymes will never be correctly annotated in the major biological 
database. Moreover, the broken linkage between enzymatic functions and their cognate 
sequence form a barrier in molecular data-driven studies. For example, the genome-
scale metabolic network, a simplified mathematic representation of a living organism, 
serves as an important platform in system biology. The network reconstruction requires 
high quality and accurate genome annotations. The existence of orphan enzymes, the 
missing pieces of metabolic knowledge, results in incomplete models that contain 
network gaps. Errors could be introduced into the final metabolic models when filling the 
network gaps in the metabolic network by current approaches.  
There are several methods to associate genes with enzymatic function. The most 
common and effective way to determine protein function is the homology-based method 
in which functions are transferred on the basis of sequence similarity. Several powerful 
tools such as BLAST(14) are widely used by major public archives such as 
GeneBank(15) and UniProt(16) in routine annotation pipelines. The minimal 60% 
sequence identity is required to successfully transfer a precise enzymatic function (that 
is, a four digits EC number)(17). Our analysis (Figure 3-2) shows that by using a 60% full 
identity as a threshold for the BLAST, we are able to recover the precise enzymatic 
activities (four digits EC numbers) of 75% E. coli, 60% H. pylori and 94 % human 
enzyme present in the SwissProt database. State-of- the-art homology approaches even 
incorporate with different types of sequence and structure similarity such as motif or 
patterns of sequences. Although the homology-based methods have remarkable 
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success, they only work when (1) homologous genes exist in the search database and 
(2) the homologous genes have proper annotations. This approach fails to determine 
functions for many genes with poor or no homology to genes with known functions. 
Approximately 20-60% of proteins in most genomes have no assigned function because 
of a lack of good match in the existing archives(18). It is pretty clear that the traditional 
homology-based approach cannot help fill the gaps of global orphans since we have no 
clue what their sequences are. The inability to annotate all enzymes using homology-
based methods leaves a massive information gap in current knowledge. 
 
Figure 3-2. The precision under different identity cutoff when trying to assign the precise 
EC number to human, H. pylori and E. coli proteins in SwissProt. For each organism, we 
first assume all proteins have no EC annotations, and then try to assign the four digits EC 
annotation based on the rest of the proteins in the database using BLAST. Here, the 
identify is defined as the alignment length, which includes gaps  
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Several non-homology-based methods have been developed to capture the conserved 
functional relationship between genes and/or proteins. Those methods called context-
based methods and often provide information complementary to sequence homology. A 
common theme of those methods is the integration of various types of evidence such as 
phylogenetic profiles(19, 20), protein fusion(21) and gene co-expression(22, 23) to infer 
functional coupling for proteins participating in related cellular processes. Although those 
evidences are less precise than the sequence homology, they can be complementary to 
sequence homology. In addition, it is advantageous to combine sequence homology and 
context-based information to maximize the prediction power. 
Orphan enzymes can be seen as network gaps in the genome scale metabolic network. 
Green et al. developed PHFiller-GC(24) to fill network holes during metabolic network 
reconstruction. This tools is integrated into the automatic annotation pipeline used by the 
MetaCyc(25)/BioCyc(26) databases. Another famous database hosted by the Fellowship 
for Interpretation of Genomes (FIG), SEED, implemented a subsystems approach(27). 
Each subsystem represents a manually curated collection of functional roles that makes 
up a pathway, a complex or a class of proteins. When a gap is found, bioinformatics 
tools can be used to infer the genes in the target organisms based on other genes in 
many different genomes in the same subsystem. Recently, Plata et al. developed a new 
algorithm “GLOBUS,” which stands for GLObal Biochemical reconstruction Using 
Sampling(28). GLOBUS assigns genes to a generic metabolic network that contains all 
possible metabolic activities characterized in the EC system. To reliably project genes 
into the metabolic network, Gibbs sampling is used to determine the best candidate 
network location of each gene. However, the biochemical properties of the orphan 
enzyme activities are ignored in their probability model. Meanwhile, Yamada et al. 
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utilized the pathway information of the orphan enzymes and the genomic neighbor 
information to assign candidate proteins to the orphan enzyme activities(29). This 
method is limited to orphan enzymes with pathway annotations only and genomes with 
high coverage. Another drawback of these methods is small coverage. The methods 
have only been tested in orphan enzymes in microbial. Using BRENDA database as an 
example, GLOBUS and Yamada’s methods can only solve a small proportion of gaps 
(see Figure 3-3). 
  
Figure 3-3. The overlap between orphan enzymes in BRENDA and orphan enzymes solved 
by GLOBUS and Yamada’s approach. The dark circle represents 14,948 bacteria orphan 
enzymes (global + local) claimed by BRENDA. The green circle  represent 5.044 
predictions made by GLOBUS and Yamada. The intersection between them is 38. 
 
Some biologists try to solve the orphan enzyme problem with other approaches. For 
instance, one of the bottlenecks in the experiment of determining protein function is to 
get the protein assay to work properly, which may involve troubleshooting and optimizing 
experimental protocols. Ramkissoon et al. found that some orphan enzymes actually are 
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commercially available (or sit in some researchers’ freezers)(8). In their work, two 
protein samples were obtained—one from a laboratory chemical supply company and 
the other one from other researchers—and their protein sequences were identified with a 
mass-spectrometry based approach without actually sequencing proteins. Shearer et al. 
focused on fixing the errors in the public data archives(12). They build a database 
search and literature review pipeline to “reconnect” 270 orphan enzymes with their 
genetic information from public databases. 
Enzymes play a crucial role in human health. The malfunction of enzymes leads to 
pathological conditions. Many metabolic diseases are caused by insufficient quantities or 
deficiency in the activity of specific enzymes. For instance, phenylketonuria, one of the 
common inherited diseases in which the patient’s body cannot break down 
phenylalanine, is caused by the absence of phenylalanine hydroxylase, an enzyme that 
catalyzes phenylalanine. A recent update of BRENDA database shows that 1,756 
enzymatic functions are associated with 3,852 disease conditions. The relationship 
between enzymes and diseases in BRENDA is categorized into four main categories: 
therapeutic application, causal interaction, diagnostic usage and others (ongoing 
research). We examine the disease-enzyme relationship with the highest confidence 
level in BRENDA and found that 1,101 and 1,322 enzyme activities have therapeutic 
applications and diagnostic usages, respectively (see Figure 3-4). Deciphering the 
sequences of enzymes could benefit the drug development process and human health. 
In addition, in a 2005 review(30), Robertson listed 71 enzymes that are the targets of 
FDA-approved drugs. Those enzyme-based drugs inhibit 48 human, 13 bacterial, 5 viral, 
4 fungal and 1 protozoal enzymes. Unexpectedly, 6 human drug targetable enzymes are 
still listed as orphans in BRENDA. The mechanism of the drugs may be well 
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characterized but the exact sequences of the target proteins in humans are still unclear, 
or at least not well documented in the major biological databases. 
 
Figure 3-4. The number of disease-related EC in each category 
 
Therefore, developing a new approach to identify the sequences of orphan enzymes is 
critical. Eventually, closing the gaps of orphan enzymes requires experimental validation, 
which is labor-intensive and time-consuming. However the computational identification of 
orphan enzymes will reduce the search space and guide biologists to explore the correct 
targets. In this chapter, we present a new computational framework that integrates 
several different resources to identify candidate genes for orphan enzymes and use 
orphan enzymes in humans as a case study. 
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3.2 Method 
In contrast to other approaches, our new computational framework takes into account 
the biochemical properties of each reaction, and integrates multiple evidence to globally 
fill the knowledge gaps. Instead of directly searching for the proteins catalyzing orphan 
enzyme activities in the species of interest, we are first interested in the proteins 
involved in other biochemical activities related to the target enzyme activities. Our 
assumption is that if two reactions are similar, then the enzymes responsible for those 
two reactions may be also closely related. A similar idea has been applied by Kotera 
et.al. and Yamanishi et al. to automatically assigning the EC numbers to fully or partially 
characterized reactions(31, 32). However, this hypothesis has not yet been applied to 
predict proteins responsible for enzyme activities. The relationship between genes can 
be inferred from a homology-based approach or directly from the Functional Linkage 
Network (FLN)(33, 34), which integrates multiple types of evidence.  
Our hypothesis has been tested by using protein annotated in the COMBREX database. 
First, we use the KEGG RCLASS database to build a similarity matrix of all reactions 
characterized in the EC system for accessing how close two reactions are in further 
usage. The KEGG RCLASS database is a manually curated collection of reaction 
clusters. Reactions are categorized by their chemical structure transformation patterns, 
which is defined by atom type changes of the KEGG REACTANT Pairs(32, 35) (a 
manually curated set of the substrate-product pair of reactions). Each reaction may be 
associated with more than one KEGG REACTANT Pairs; therefore, one KEGG reaction 
could be classified into more than one KEGG RCLASSes. In the analysis of all 
COMBREX proteins, we found that about one-fourth of enzymes in COMBREX could 
catalyze multiple related reactions (reactions in the same RCLASS). In addition, there 
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are 2,155 protein clusters(6) (a set of proteins sharing a high degree of sequence 
similarity) the members of which can catalyze multiple similar reactions. For example, 
two E. coli proteins NP_418478.1 (tryB) and NP_415448.1 (aspC) are members of the 
protein cluster PRK09257-aromatic amino acid aminotransferase. Proteins in the same 
protein cluster indicate a high degree of sequence homology among them. The 
annotations in the COMBREX database show that these two proteins in fact would 
perform two different but similar enzymatic functions: NP_418478.1 for EC 2.6.1.57 - 
aromatic-amino-acid transaminase and NP_415448.1 for EC 2.6.1.1 - aspartate 
transaminase. This example supports our hypothesis that proteins performing similar 
biochemical reactions will also be closely related. In addition, other evidence such as 
sequence-based metrics and the context-based metrics will be incorporated into our 
framework to expand the search space and increase accuracy. We therefore reasonably 
expect that our new approach could enrich our knowledge of the protein universe by 
filling information gaps. 
3.2.1 Introduction of EC system 
EC number stands for “enzyme commission” number; it is a system of enzyme 
nomenclature that is maintained by the Nomenclature Committee of IUBMB (NC-IUBMB). 
Enzyme activities are organized in a top-down hierarchy (‘tree”-like) structure. Each EC 
number is a four-digit numbers that represents a specific enzymatic activity. For example, 
an enzyme with an EC number of 3.1.1.29 indicates that this enzyme falls into the 
following categories. 
- EC 3  hydrolase 
- EC 3.1 a hydrolase acting on ester bonds 
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- EC 3.1.1 a carboxylic ester hydrolase 
- EC 3.1.1.29 a aminoacyl-tRNA hydrolase that will catalyze the following reaction 
N-substituted aminoacyl-tRNA + H(2)O <=> N-substituted amino acid + tRNA 
Currently, six top enzyme classes are defined in the EC hierarchy (distinguished by the 
first position in the EC number) 
 EC 1 - oxidoreductases 
 EC 2 - transferases 
 EC 3 - hydrolases 
 EC 4 - lyases 
 EC 5 - isomerases 
 EC 6 - ligases  
The second and third digits of EC refer to the subclass and sub-subclass, respectively. 
The last digit specifies substrates and cofactors. EC system categorizes enzymatic 
reactions, not the enzymes-the protein catalyzing the reaction-themselves. Therefore, 
proteins in the same EC category may come from different organisms. Similarly, a 
multiple function protein that can catalyze multiple enzymatic activities will be associated 
with more than one EC number. Notably, the order of EC numbers in the same level has 
no meaning. For instant, EC 2.3.1 is not superior to EC 2.3.2, or vice versa. 
While an existing EC number may be deleted or transferred to another EC number, new 
orphan enzymes may be created along with the evaluation of the EC hierarchy. For 
instance, a former EC number 2.1.1.23-protein-arginine N-methyltransferase was split 
into three different EC numbers by the curator for better defining the enzyme activates. 
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 EC 2.1.1.124 [cytochrome c]-arginine N-methyltransferase 
 EC 2.1.1.125 histone-arginine N-methyltransferase 
 EC 2.1.1.126 [myelin basic protein]-arginine N-methyltransferase 
After EC 2.1.1.23 was deleted, EC 2.1.1.125 inherited the proteins previously associated 
with EC 2.1.1.23. This change in the EC hierarchy immediately produced two provisional 
global orphan enzymes: EC 2.1.1.124 and EC 2.1.126. 
3.2.1 Identifying orphan enzymes in humans 
We compiled a list of orphan enzymes in humans by querying the BRENDA database. 
BRENDA is a comprehensive public database that hosts a wide range of data, including 
genetic data, kinetic data etc., in enzymology for the community. We chose BRENDA as 
our primary source of orphan enzymes because it directly provides the information about 
local and global orphan enzymes. Local orphan enzymes in humans are human 
enzymes with sequences that are still unknown, but genes/proteins of the enzymes 
catalyzing exactly the same biochemical reaction in other organisms have been 
identified. Knowledge of local orphan enzymes is limited. This type of information usually 
cannot be found in the major gene or protein archives since they mainly provide 
annotations for known genes, not information for biochemical activities. In contrast, 
global orphan enzymes seem to attract more attention from the scientific community. For 
instance, ORENZA (Orphan ENZyme Activities)(13) is a database collating information 
about enzyme activities not associated with any sequence in the major public databases. 
Although ORENZA aims to be a useful resource for biologists who are interested in the 
orphan enzyme problem, the database still lacks data of local orphan enzymes. A similar 
project, Orphan Enzyme Project, generated a list of orphan enzymes by searching 
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multiple biological databases, including ORENZA. Again, the evaluation pipeline does 
not take into account the species-specific information and therefore yields a list of 
putative global orphan enzymes. 
An initial list of human orphan enzymes was assembled by querying BRENDA database 
via the SOAP web service. We first identify all human-related EC numbers and their 
corresponding sequences data from BRENDA. An EC number that is associated with 
Homo sapiens but has no link to a protein will be considered an orphan enzyme. We 
further cross-check this list against information of other species in BRENDA. If a human 
orphan enzyme links to a known protein in other species, then this enzyme will be local 
in humans; otherwise, the enzyme will be a global orphan. In BRENDA (Sep 2013), 
there are 1,541 ECs associated with human. Of these, 556 are orphans, including 206 
global orphans with sequences that are unknown in all organisms and 350 local orphans 
in which the enzyme was sequenced in at least one species. 
3.2.3 Determining the similarity between biochemical reactions 
Reaction similarity is not a brand-new concept. For instance, the EC system we have 
described can be seen as a type of qualitative measurement of the similarity between 
enzyme activities. EC numbers under the same branch in the EC hierarchy are in the 
same subclass or sub-subclass. Unfortunately, the EC system only expresses a top-
down hierarchy relationship between enzymatic reactions; it conveys no information 
about the relationship between enzymatic reactions within the same group. Alternatively, 
other approaches, such as CATH(36) and SCOP2(37), classify the catalyzing enzymes 
form the protein structure and/or the evolutionary perspective. 
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Our computational framework does not restrict the use of the similarity metric in the 
analysis. Any metric that can properly represent the similarity (or distance) between 
biochemical reactions should be compatible with the framework. In the following work, 
we use the KEGG RClass database to determine the similarity between enzymatic 
reactions. The KEGG RCLASS database is a manually curated collection of reaction 
clusters. Reactions in the same RCLASS share a common chemical structure 
transformation pattern. The RCLASS database includes 75% of the enzymatic reactions 
listed in the EC system. One reaction can be associated with multiple RCLASSes. 
However, most of the RCLASS are small. We define the similarity scores between two 
enzymatic reactions as the number sharing RCLASSes between them. The more shared 
RCLASSes between two reactions, the higher the similarity score between them. 
3.2.4 Inferring the gene-gene relationship from a functional linkage network 
We hypothesize that if the products of two genes can catalyze two different but similar 
reactions, then these two genes may also be closely related. We show an example by 
using the microbial genes in COMBREX previously. In this example, the gene-gene 
association is determined by the NCBI Protein Cluster. This collection currently only 
consists of clusters for proteins in archaea, bacteria, plants, fungi, protozoans and 
viruses and is constructed primarily based on sequence similarity. To work on the 
human orphan enzyme problem, we use a genome-scale human functional linkage 
network (FLN) to infer the gene-gene correlation. The success of the FLN had been 
shown in several different contexts such as functional annotation, prioritizing disease 
candidate genes and discovering new disease-disease associations. The one we used 
was built by Linghu et al. (34), who constructed it by integrating 16 genomic features, 
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including data from co-expression, protein-protein interaction, protein domain sharing etc. 
It has better coverage and comparable accuracy. On the FLN, the nodes represent 
genes and are connected by undirected weighted edges representing the degree of the 
overall functional association between genes. Because several non-homology-based 
evidences complement sequence similarity for determining the likelihood of genes 
participating in a common biological process, the FLN provides more information than 
the NCBI Protein Cluster which relies on only single evidence. In our computational 
framework, the FLN is used to find the closely related genes of a gene that performs a 
particular enzymatic activity. We remove edges that fail to meet the threshold to exclude 
low confidence associations and to reduce computational loading. 
3.2.5 Identifying the candidate gene for orphan enzyme 
The first phase of the computational framework is to identify the candidate genes for 
orphan enzymes. We first construct an enzyme activity similarity matrix based on the 
KEGG RCLASSes database. The similarity score is defined as the number of the 
common RCLASSes between two biochemical activities. For each human orphan 
enzyme found in BRENDA, we first check its similar enzyme activities on our matrix. 
Orphan enzymes that have no similar enzyme activities (0 similarity scores to all other 
enzyme activities) are filtered out. Those orphan enzymes may represent singletons in 
the protein universe, or they may exist because of our limited knowledge. Each qualified 
orphan enzyme will have a set of associated enzyme activities with a varying degree of 
similarity. The next step is to identify the genes responsible for those associated enzyme 
activates. Here we use the KEGG database as our primary data source. Next, those 
genes will be projected onto the human FLN. Since FLN is a condensed network that 
preserves lots of weak correlations, we remove all low confidence associations (edge 
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weight <0.15) from the network. The immediate neighbors (the first degree nodes) of 
those genes are the candidates of each orphan enzyme. The number of candidates per 
orphan enzyme varies. We will assess the likelihood of connecting a candidate with an 
orphan enzyme by using a machine learning approach in the next phase. 
3.2.6 Prioritizing the candidate genes 
3.2.6.1 A supervised learning model to prioritize the candidates 
By combining the gene-gene functional association (from FLN) and the reaction-reaction 
similarity (from KEGG RCLASS), we can identify a set of candidates for each orphan 
enzyme. The next question is which candidate is more likely to be the genes that 
catalyze the orphan enzyme activities. To answer this question, we use a supervised 
learning procedure to integrate other evidence and prioritize the candidate genes of 
each orphan enzyme. 
Each candidate can be seen as a (EC, GENE) pair. Therefore, our goal is to determine if 
a particular (EC, GENE) pair is true (the GENE’s product is responsible for that particular 
EC) or false (the GENE is not associated with the particular EC at all). We use a 
supervised machine learning approach to classify each (EC, GENE) pair based on a set 
of features. Features include data from the following 7 data sources: FLN, reaction 
similarity, pathway, co-occurrence, conserved Neighborhood and Pfam domain. Each 
data will contribute one or multiple components to our feature vectors. Two data 
matrices are constructed: one from the available knowledge for training the model and 
the other one containing the orphan enzymes that we want to solve. 
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3.2.6.2 Integrating with other genome-context based evidence 
For each orphan enzyme, we first construct a heterogeneous evidence network based 
on the FLN and reaction similarity we described previously. Figure 3-5 shows a toy 
example. In the diagram, a rectangle represents an enzyme activity and a circular 
represent a gene. The edges connecting enzyme activities indicate the similarity 
between them; data are calculated based on KEGG RCLASS. Genes are connected by 
FLN. The gray enzyme activity in the top left corner is our target, and all red genes are 
its candidates. We will project other genome-context based evidence onto the evidence 
network and then calculate to features.  
In our data source, FLN, co-occurrence and conserved Neighborhood are network type 
data that describe the relationship between genes. For FLN, we use the one built by 
Linghu et al.(34), which is available on VisANT. For co-occurrence and conserved 
neighborhood, we download data from the STRING database(38). The evidence network 
already contains the information from FLN. When calculating features of other evidences 
such as the co-occurrence and conserved neighborhood, we switch the FLN weighted 
with the evidence/confidence score provided by other methods. For each type of network 
data, we will calculate the following 5 features: 
1. degree of effective edges. (the edges support the association between target 
enzyme activity and candidate gene); 
2. average effective weighting; 
3. maximum effective weighting; 
4. minimum effective weighting; and 
5. summation of effective edge weighting. 
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Figure 3-5. A toy example demonstrates the heterogeneous evidence network based on 
the FLN and reaction similarity. 
 
The correlation between reactions will also be part of the features. They are derived from 
the reaction similarity matrix and the KEGG Pathway. For the reaction similarity matrix, 
we calculate the following two features: 
1. number of associated enzyme activities. For instance, in Figure 3-5, “Gene J” 
becomes a candidate because it is highly associated with “Gene a” and “Gene b”. 
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“Gene a” is responsible for “EC x.y.z.a” but “Gene b” is a multifunction gene 
whose gene product can catalyze “EC x.y.z.a” and “EC x.y.i.k.” Therefore, this 
particular pair (EC x.y.z.w, Gene J) will have 2 associated enzyme activities; and 
2. maximum number of shared RCLASSes. 
For KEGG Pathway, we use the following 3 features: 
1. number of effective enzyme activities that are in the same KEGG pathway with 
the target enzyme activity; 
2. maximum number of the common KEGG pathway; and 
3. minimum number of the common KEGG pathway. 
Protein domains are a good proxy for protein function. To incorporate the domain’s 
information into the feature space, we first calculate the following metrics: 
1. for each Pfam domain, the probability of being an enzyme protein if a protein has 
particular Pfam domain; and 
2. for each Pfam domain associated with an EC, the probability of the gene being 
associated with a particular EC number if it has this Pfam domain.  
We will project those two metrics onto our data matrices and add the following nine 
features to each (EC, GENE) pair: 
1. the number of Pfam that GENE has; 
2. The maximum probability of having an enzyme activity from the domains that the 
GENE has; 
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3. the minimum probability of having an enzyme activity from the domains that the 
GENE has; 
4. the average probability of having an enzyme activity from all domains that the 
GENE has; 
5. the number of domains that the GENE has that is associated with the EC; 
6. the number of domains associated with EC/total number of domains; 
7. the maximum probability of having a particular enzyme activity based on the 
Pfam domain annotation. A protein may have multiple domains and each domain 
is associated with one or more enzyme activities with a probability. Here we will 
use the maximum probability from the domains that is associated with the target 
enzyme activity as a feature; 
8. the minimum probability of having a particular enzyme activity based on the Pfam 
domain annotation. Similar to the previous item, but we select the minimum 
probability; 
9. the average probability of having a particular enzyme activities based on the 
Pfam domain annotation. Similar to the previous item, but we take the average. 
3.2.6.3 Gold standard data set 
Building a supervised learning model requires a training processing. In our framework, 
since our model can be seen as a binary classification problem (the candidate is either 
true or false), it is necessary to have a gold standard data set that contains the true-
positive set and the true-negative set. Identifying a set of the true-positive usually is a 
straightforward procedure. This type of information (that is, the enzyme annotations) can 
be pulled from the major databases. On the other hand, it would be relatively difficult to 
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build a true-negative set; the major data repositories usually do not hold such negative 
findings. 
Only very few databases have the capability of maintaining negative results. Gene 
Ontology is one example. A GO annotation with a ‘NOT’ qualifier explicitly indicates that 
the gene product is not associated with a particular GO term. Unfortunately, the scientific 
community has a long history of ignoring negative results. Only a small portion of the 
annotations in GO has the ‘NOT’ qualifier. Therefore, we would have to seek other 
approaches to compile a true-negative set. 
There are several approaches to construct a true-negative set. Shen et al(39) built a set 
of non-enzyme proteins by randomly sampling proteins from Swiss-Prot. This type of 
approach does not consider any other factors such as the protein domains. Due to the 
limited knowledge in enzymology, this approach fails to exclude all true enzyme proteins 
in the non-enzyme proteins set. Here, we use Wei’s et al.(40) approach, which utilized 
protein domain knowledge to compile a non-enzyme protein set. 
Protein domain is the smallest functional unit for capturing the protein function. A protein 
may be comprised of several protein domains, and each domain has a distinct structure 
or molecular function. To construct a non-enzyme protein set, we first divide Pfam 
domains into two groups: Pfam enzyme domain and Pfam non-enzyme domain. The 
Pfam enzyme domain is a Pfam domain that exists in a protein that will perform an 
enzyme activity. The remaining Pfam domain will be Pfam non-enzyme domain. An 
Pfam enzyme domain does not have to be directly correlated with an enzyme function, 
as long as the domain appears in a protein involved in enzyme activities. By doing so, 
we may end up having a bigger Pfam enzyme domain collection that contains some 
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domains actually not associated with any enzyme activates. On the other hand, we will 
also reduce the false-positive rate of the Pfam non-enzyme domain set since we 
minimize the chance of including a putative enzyme domain in this Pfam non-enzyme 
domain collection. By performing a cross-database comparison, we identify 3,327 Pfam 
enzyme domains and more specifically, 2,843 Pfam non-enzyme domains that are 
present in humans. 
Once we partition the Pfam domains into two categories, we can start selecting the 
proteins that only have Pfam non-enzyme domains. Those proteins will be the non-
enzyme proteins since there is no strong evidence that these proteins will catalyze 
enzymatic reactions. We will exclude proteins that do not have domain annotations 
because there is not sufficient information to determine their categories. In all, we 
identify 5,932 non-enzyme proteins in humans. To build the training data, we first 
construct the heterogeneous evidence networks for each known enzyme activities (that 
is, EC number) in humans and then project the gold standard data set onto the network. 
In the training data matrix, a (EC, Gene) pair will have a false label if the gene is a non-
enzyme protein. In contrast, a (EC, Gene) pair will have a true label if and only if the 
connection between the particular EC and the particular Gene is known. The rest of the 
unlabeled data will be removed from the training data. The resulting training matrix 
contains 929 true and 111,843 false (EC, GENE) pairs.  
3.2.6.4 Handling the imbalanced dataset 
We build a training matrix in which a (EC, GENE) pair would be either true or false. 
However, the data matrix has a skewed class distribution. The true recorders only 
contribute a small proportion of the data matrix; the majority of the data fall into the false 
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category. Many standard machine learning algorithms prefer constructing the model by 
performing the learning from a balanced data set. An imbalanced data set may 
significantly compromise the performance of a machine learning algorithm because of 
underrepresentation of data. However, the imbalanced dataset occurs naturally in reality; 
many of the real world problems are characterized by imbalanced dataset. For instance, 
in the fraud detection problem, the major category that represents normal activities 
dominates the data set. Only a very small fraction of records is actually fraud. To 
compensate for the class imbalance in the training data, we use MetaCost(41), a general 
cost-sensitive machine learning framework, to wrap a RandomForest to build a binary 
classification model. MetaCost is one of the bagging ensemble methods. By 
incorporating a predefined cost matrix that describes the misclassification cost of each 
category, MetaCost treats the underlying based-classifier as a black box and implements 
a cost-minimizing procedure for making the model cost-sensitive. More details about 
MetaCost can be found in Domingos’ paper (41). We chose the RandomForest, an 
elegant classification method that aggregates numerous weak classifiers (by default, the 
decision tree) into one big effective classifier, as the based classifier in MetaCost for our 
framework. To minimize the false positive rate, we use the [10000: 1] as the 
misclassification cost matrix in building the model. 
3.2.6.5 Performance assessment  
Performance of the framework is estimated by a stratified 10-fold cross validation. 
Before building the actual model, the training data order is shuffled, and then the training 
data matrix is partitioned into 10 equal size subsets. Each time, a subset is used as test 
data to determine the sensitivity and specificity and the other 9 subsets are used for 
training the classifier. The overall performance is accessed by the average of results 
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from the 10 rounds. To estimate the stability of our model, we also construct the model 
20 times (based on the same training data) and investigate the performance among 
them. 
3.3 Results and discussion 
3.3.1 Human orphan enzymes  
In BRENDA database, 1,540 EC are associated with human. Of these, 556 are not 
associated with any proteins. Therefore, 206 are global orphan enzymes, and the 
remaining 350 are local orphan enzymes. The detailed distribution of enzymes in each 
EC category is shown in Figure 3-6. The majority of the human-associated EC are in EC 
1 - Oxidoreductases, EC 2 - Transferases and EC 3 - Hydrolases. The distribution of 
orphan enzymes in humans follows the same trend. EC 3 - Hydrolases has the most 
abundant enzymes as well as orphan ones. EC 4 - Lyases, EC 5 - Isomerases and EC 6 
- Ligases have small numbers of orphan enzymes, most of which are local. For each of 
the identified human orphan enzymes, we construct an evidence network to identify the 
candidate genes. There are 258 orphan enzymes that fail to have candidates because 
either those enzyme activities are not similar to any other known enzyme activities or the 
genes responsible for the similar enzyme activities are also unknown or have no 
connected neighbors in the evidence network. Our framework provides candidates for 
298 orphan enzymes in humans. 
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Figure 3-6. EC and orphan enzymes associated with humans 
 
3.3.2 Performance  
A supervised machine learning procedure that integrated several genome-context 
features is used to prioritize the candidates and identify the genes that are most likely 
responsible for each orphan enzyme in humans. The detailed procedure is described in 
the method section. Briefly, the core of the model is based on MetaCost, a general cost-
sensitive machine learning framework that wraps a RandomForest classifier to manage 
the imbalanced data set. From the known EC-Gene association in KEGG and the Pfam 
domain annotation, we first construct a gold standard data set. The performance of the 
machine learning model will be estimated by performing a stratified 10-fold cross 
validation on the gold standard data set. 
The true-positive rate and the false-negative rate estimated from 20 runs of the stratified 
10-fold cross validation is 68.19% and 99.74%, respectively. The variation among 20 
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runs is small. The true-positive rate (sensitivity) and the true-negative rate (specificity) of 
20 runs seem very consistent (Figure 3-7). The relatively lower sensitivity indicates that 
some of the “true” candidates may have been missed by our approach. Adjusting the 
mis-classification cost in the model may increase the sensitivity but may also increase 
the chances of introducing more false-positive predictions in the final output.  
 
Figure 3-7. Sensitivity and specificity of 20 runs 10-fold cross validation. 
 
3.3.3 Predicted genes of human orphan enzymes  
To utilize all available knowledge and maximize predictive accuracy, we build a final 
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assess the likelihood that a candidate is associated with a particular EC for all 298 
qualified orphan enzymes in humans. To minimize the uncertainty caused by random 
noise, we also run the framework 20 times and then compile the final prediction by 
aggregating the outputs from 20 runs. At the end, our computational framework assigns 
gene candidates for 82 orphan enzymes. On average, each orphan enzyme has 4.55 
candidates. EC 3.6.1.15 - nucleoside-triphosphate phosphohydrolase receives the most 
abundant candidates from our framework. We associate 41 genes with this orphan 
enzymes based on evidences we current have. In addition, 34 orphan enzymes have 
only one associated candidate. The number of solved orphan enzymes in each EC 
category is shown in Figure 3-8. 
 
Figure 3-8. Number of solved human orphan enzyme in each EC category 
 
Most of the solved orphan enzymes are in EC 1, EC 2 and EC 3 because most of the 
human-associated EC and human orphan enzymes are in these 3 categories. Although 
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EC 4 - Lyases has 7 global orphan enzymes and 25 local orphan enzymes in humans, 
our pipeline did not associate any genes with them. The failure to predict EC 4 suggests 
that the reaction similarity matrix we chose may not suit this EC category. In addition, 
our framework successfully associates genes with 7 out of 206 global orphan enzymes 
in humans. The lower success rates in human global enzymes are largely due to lack of 
knowledge. The complete list of resolved orphan enzymes is in Appendix D. 
Our putative human orphan enzyme list is mainly based on the annotations in BRENDA. 
We compare our predicted result with the annotations in other biological databases and 
found that some of the orphan enzymes in our list may have been associated with 
genes/proteins in other biological database. Those pseudo-orphan enzymes can serve 
as another type of qualitative performance indicator to evaluate the actual performance 
of our framework. We found that in our list, 32 (39.02%) orphan enzymes, equivalent to 
48 (EC, Gene) pairs, match the functional annotations in other databases. Those 
enzyme activities are listed as orphan (no corresponding proteins in BRENDA), but their 
associated genes can be successfully recaptured by our framework. The high successful 
rate also confirms the correctness of our hypothesis and the usefulness of our new 
approach. By excluding those pseudo human orphan enzymes from our prediction, we 
compile a new list named novel predictions that only contains the true orphan enzymes 
in humans. 
The novel prediction list has 33 orphan enzymes, including 5 global orphans and 28 
local orphans, in humans. The 5 global orphan enzymes are: 
EC 2.3.1.68 - Glutamine N-acyltransferase; 
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EC 2.3.1.192 - Glycine N-phenylacetyltransferase; 
EC 2.7.1.140 - Inositol-tetrakisphosphate 5-kinase; 
EC 3.1.4.38 - Glycerophosphocholine cholinephosphodiesterase; and 
EC 3.5.4.14 - Deoxycytidine deaminase. 
They are orphans when we compile our orphan list and the data matrix. With the new 
knowledge (new sequenced genome, newly identified biochemical activity, etc.) that is 
continuing to emerge and updates in the EC hierarchy, some of them are not global 
orphans any more. For instance, EC 3.5.4.14 - Deoxycytidine deaminase was deleted 
and transferred to another record: EC 3.5.4.5 - cytidine deaminase. EC 2.7.1.140 - 
Inositol-tetrakisphosphate 5-kinase is still listed as a global orphan in the BRENDA 
database. Three organisms, Bos taurus, humans and Rattus norvegicus have this 
enzyme but the exact proteins/genes of this enzyme are still unknown. However, 
UniProtKB associates four proteins with this enzyme activity; two are proteins in rice and 
the other two are proteins in mouse-ear cress. Our framework suggests seven gene 
candidates, IP6K3, IPMK , ITPKA,  ITPKB, IP6K2, ITPKC and IP6K1, that may catalyze 
EC 2.7.1.140 in humans. Another enzyme activity, EC 2.3.1.192, was originally purified 
from bovine liver mitochondria. It is still a global orphan in BRENDA, but UniProtKB 
annotates one bovine protein, GLYAL_BOVIN, with this function. The human protein 
responsible for this enzyme activity is still unknown. Our framework suggests a human 
gene, GLYATL - 2 glycine-N-acyltransferase-like 2, to EC 2.3.1.192. The BLAST 
analysis shows that the gene product of our human candidate, GLYL2_HUMAN, has 
high degree similarity to the bovine protein GLYATL_BONIV (E-value: 31E-75, identity: 
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42.9%). The last human global orphan, EC 2.3.1.68 - Glutamine N-acyltransferase, has 
no associated sequences in BRENDA. In UniProtKB, a human protein GLYL1_HUMAN 
is associated with this function. Interestingly, our framework also assigns the human 
gene, GLYATL - 2 glycine-N-acyltransferase-like 2, to this enzyme activity. Although 
there is no strong evidence to support our predicted annotation for EC 2,3,1,68, the 
sharing Pfam domain composition among GLYL1_HUMAN and GLYL2_HUMAN may 
give some clues to what the protein function is. 
The novel prediction list also includes 28 human local orphan enzymes. For instance, 
our framework associates two human genes, ME1 and ME3, with EC 1.1.1.39 - Malate 
dehydrogenase (decarboxylating). Malic enzymes have three isoforms in mammals. 
They are cytosolic NADP-dependent malic enzyme, mitochondrial NADP-dependent 
malic enzyme and mitochondrial NAD(P)-dependent malic enzyme. Both our candidates, 
ME1 malic enzyme 1 (NADP(+)-dependent, cytosolic) and ME3 malic enzyme 3 
(NADP(+)-dependent, mitochondrial), currently associate with EC 1.1 1.40 - Malate 
dehydrogenase (oxaloacetate-decarboxylating) (NADP(+)) in NCBI. However, the Gene 
Ontology Annotation Database indicates that both are also associated with malate 
dehydrogenase (decarboxylating) (NAD+) activity (evidence code: IEA), which is 
equivalent to EC 1.1.1.38 or EC 1.1.1.39. In addition, ME3 has multiple alternatively 
spliced transcript variants. Some of the variants have not been characterized yet. They 
could be possible related with the function of this human orphan enzyme. Another 
example is orphan enzyme EC 1.1.1 88 - hydroxymethylglutaryl-CoA reductase. HMG-
CoA reductase is a rate controlling enzyme of mevalonate pathway, a pathway that 
produces cholesterol and other isoprenoids. This enzyme has one related enzyme: EC 
1.1.1.34 - NADPH-dependent enzyme. We assign human gene HMGCR with the orphan 
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enzyme orphan enzyme EC 1.1.1 88. This gene currently is annotated with EC 1.1.1.34 
in NCBI, while the Gene Ontology Annotation Database also associates this gene with 
hydroxymethylglutaryl-CoA reductase activity (GO:0042282)/IDA, which is equivalent 
with EC 1.1.1.88. Another good example is local orphan enzyme EC1.2.1.19 - 
aminobutyraldehyde dehydrogenase. BRENDA does not associate any human protein 
with this enzyme activity. We predict 8 candidate genes for EC 1.2.1.19. One is 
ALDH9A1 and its gene product is annotated with the following 3 enzyme activities in 
NCBI:  
EC 1.2.1.19 - aminobutyraldehyde dehydrogenase; 
EC 1.2.1.31 - Aldehyde dehydrogenase (NAD(+)); and 
EC 1.2.1.47 - 4-trimethylammoniobutyraldehyde dehydrogenase. 
The full novel prediction list is in Appendix E. 
3.5 Conclusions  
We present a new computational framework that incorporates the properties of 
biochemical reactions to target the orphan enzyme problems. To demonstrate the 
capability of this framework, we select the orphan enzymes in humans as a case study. 
Our method is not intended to replace the biologists’ work. Instead, our method aims to 
guide biologists to identify the most likely sequences of each orphan enzyme. Therefore, 
the exact sequence of orphan enzymes can be biochemically determined. On average, 
our framework assigns 4.5 candidate genes to each orphan enzyme. Prescreening by 
the computational approach will help biologists narrow down the search space and 
speed up the experimental annotation work.  
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Furthermore, most of the automated genome annotation pipelines still use the 
homology-based strategy since the annotation procedure is transparent and the result is 
mostly predictable. Here, we demonstrate a novel strategy that combines several 
biological evidences to solve the orphan enzyme problem. Since we do not only rely on 
the sequence information, our method can complement the traditional approach and 
potentially can provide more candidates for the global orphan enzyme. Our method is 
the first computational approach that is specifically tested on humans. Given the 
promising result shown here, we believe that our approach, by solving the orphan 
enzymes, would be able to help complete the genome annotation as well as the 
metabolic network not only in humans but also in other organisms. 
66 
 
Chapter 4. Visualization of symbiotic nutrient exchange flux networks in VisANT 
4.1 Introduction 
Microbes live as interacting community and the microbial community plays an important 
role in real life. For instance, it is estimated that there are 10 times more bacteria then 
human cells in the human body. Many of these bacteria reside in the gastrointestinal 
tract, and an imbalance in this microbial community is associated with human disease. In 
addition, the microbes in the environment participate in the global oxygen/nitrogen 
recycle. One Systems Biology approach to understanding the life of microbes is to 
examine their metabolism. A complex and complicated living organism can be simplified 
into a metabolic network, a simple mathematical representation. Using the powerful Flux 
Balance Analysis (FBA) method, this metabolic network can then be used in a computer 
simulation to examine the metabolism of an organism. FBA reduces the computational 
complexity by representing a living organism with a simple matrix. Due to its 
effectiveness, FBA has been widely applied in many research areas such as bioprocess 
engineering. 
The traditional FBA is suitable for studying the metabolic network of a single organism. 
However, microbial life exists in complex multi-species microbial communities. 
Understanding the microbe-microbe and microbe-environment interactions in these 
communities would help us understand their behavior at the ecosystem level. COMETS, 
a new simulation platform developed by Prof. Segre, makes it possible to perform a 
simulation of the exchange of metabolites in a microbial community. The high resolution 
results of COMETS, including temporal and 2D or 3D spatial information, opens a new 
window for researchers to investigate and understand microbial communities in real life. 
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The complexity of the ecosystem level metabolic networks poses a novel visualization 
challenge. Existing tools are available to visualize a metabolic network; some provide an 
automatic layout algorithm to provide a textbook-like representation and some rely on 
the manual fine tuning of networks. To the best of our knowledge, none of these tools 
are suitable for visualizing ecosystem-level metabolic networks. In this chapter, we 
introduce the metabolic network visualization suite in VisANT 5.0. By taking advantage 
of several unique features in VisANT, we can present complex data in a more intuitive 
way and guide biologists to find important subnetworks in complex metabolic networks at 
the ecosystem-level. 
4.2 Method design and implementation 
4.2.1 Metagraph-based visualization 
One of the unique features of VisANT is its multi-scale metagraph based visualization. In 
traditional biological networks, a node represents a single entity such as a gene or a 
protein, and the edges that connect the nodes represent the relationships between the 
entities. In VisANT, a metanode is a special type of node that can embed a subnetwork. 
The subnetwork inside a metanode can interact with the nodes outside the metanode. 
Metanodes are collapsible. When a metanode is collapsed, its internal subnetwork is 
temporarily invisible, but VisANT retains the connections between the internal 
subnetwork and the external nodes. This flexible visualization scheme enables multi-
scale data representation for complex biological networks. One can use a bird’s-eye 
view to look at the entire network by collapsing all the metanodes, or zoom-in and 
expand the metanodes to analyze the details of the network. 
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We take full advantage of the metagraph-based approach to render the ecosystem-level 
metabolic networks in VisANT. By default, we use a bipartite graph to represent the 
relationships between the two basic types of entities - reactions and metabolites - in a 
metabolic network. These two types of nodes, metabolites and reactions, are connected 
through directed edges to illustrate substrate-reaction-product structure. The left portion 
of Figure 4-1 shows an example of a typical biochemical reaction. Each reaction node is 
a metanode that can hold additional information, such as the gene associated with the 
reaction. For example, in the right portion of Figure 4-1, the reaction node has been 
expanded, and 4 genes responsible for this particular reaction are shown inside the 
reaction node. A simple bipartite graph can represent the metabolic network of one 
organism; however, for an ecosystem-level metabolic network, we must utilize the 
metagraph visualization again. 
 
Figure 4-1. Bipartite representation of a biochemical reaction in VisANT. 
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4.2.2 Visualization of ecosystem-level metabolic networks 
A large scale ecosystem-level metabolic network brings the visualization challenge to a 
new level of complexity. The actual size of a metabolic network varies widely. It is highly 
dependent on the specific setup that is used and the biological questions that are being 
asked. The number of chemical compounds and biochemical reactions involved in a 
living organism is on the order of thousands. For instance, an E. coli model(42) 
consisting of a simplified mathematical representation that only considers the metabolic 
activities necessary to conduct simulations contains 1,805 metabolites and 2,583 
reactions. In VisANT, this model would be rendered as a bipartite network comprising 
10,831 edges and 4,713 nodes, including metabolites, reactions, duplicate metabolites 
from exchange reactions (324) and one model metanode. A microbial community 
typically includes at least two organisms. Thus the size of a community scale metabolic 
network can grow exponentially. The network shown in case study 1 has 12,815 nodes 
and 28,749 edges. VisANT help researchers interpret microbe-microbe and microbe-
environment interactions by leveraging metagraph visualization. By default, a metabolic 
model in VisANT is encapsulated by a special metanode named the “module metanode.” 
Each model metanode represents the metabolic network of a single model. When all the 
model metanodes of an ecosystem-level network are collapsed, the complex interactions 
in each model are temporarily invisible while the cross-models interactions remain visible 
in the network. This facilitates the examination of the mutualistic exchange of or 
competition for common resources within the community. Because the model metanode 
retains all the detailed information of the model, a researcher can still zoom-in and 
examine his/her specific metabolic model of interest. 
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4.2.3.1 Symbiotic layout 
Metagraph technology provides multi-scale network visualization that enables a user to 
examine a network from different perspectives; however, the resulting networks may still 
be enormous. Without a solid layout strategy to properly organize the nodes and edges, 
a user cannot effectively identify biologically meaningful patterns or subnetworks in the 
large scale network, particularly in an ecosystem-level metabolic network. Multiple layout 
algorithms (Circle, Spoke, Spring Embedded Relaxing etc.) are available in VisANT. 
However, due to the nature and complexity of community-level metabolic networks, none 
of these layouts are able to automatically reduce network complexity and help 
researchers interpret inter-species interactions. Therefore, we implemented a new layout 
algorithm, called Symbiotic Layout, which draws an ecosystem-level network with a 
special emphasis on the reactions and metabolites involved in inter-species interactions. 
Symbiotic Layout is designed to reduce network complexity and provide an effective 
description of the ecological interactions between species in a community, which is 
mediated by metabolite exchange and competition for common nutrients.  
An example of the interaction of two organisms can be seen in Figure 4-3 and Figure 4-4. 
Each organism is represented as a model metanode, which encapsulates its genome 
scale metabolic network. Exchange reactions inside the model metanode connect the 
exchanged metabolites within the model metanode to the metabolites outside the model 
metanode, i.e., the environmental metabolites. The two model metanodes are aligned 
horizontally and the environmental metabolites, which are connected to both models, are 
placed in the center of the two model metanodes. The environmental metabolites 
associated with only one organism are placed either above or below their associated 
model metanodes. If a list of user defined non-interesting metabolites is provided, these 
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metabolites will be placed at the bottom of the network. Users can decide to whether to 
show or hide them from the network. Metabolites may play different roles in different 
models in the community. We use a simple color scheme to help emphasize the different 
roles that environmental metabolites play within the community. In particular, a 
metabolite is: (i) blue if it is secreted by both organisms, (ii) red if it is consumed by both 
organisms, (iii) light gray if one model produces the metabolite and the other consumes 
it, and (iv) dark gray if the metabolite is only associated with one model.  
If the microbial community involves more than two models, a multi-organism layout is 
automatically applied. In this layout, the model metanodes are arranged in a circular 
layout (outer circle), and the shared metabolites form a small circle in the middle within 
the outer circle comprising by the model metanodes (Figure 4-5). The metabolites that 
are only exchanged in one model are placed outside the circle of models. The identical 
color scheme described above is applied to the environment metabolites: (i) blue if the 
metabolite is only a by-product in the community, (ii) red if the metabolite is only 
consumed by the models in the community, (iii) light gray if some models produce the 
metabolite and some models consume it, and (iv) dark gray if the metabolite is only 
associated with one model. Because the flux may be time-dependent, the color and the 
direction of the flux may change over time to reflect the corresponding type of interaction 
being mediated. The details of this dynamic flux visualization will be described in the 
next section. 
4.2.3.2 Dynamic flux visualization 
When flux information is absent, the metabolic network is drawn with all the potential 
reactions as defined by the metabolic models and all the possible exchanges defined by 
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the ecosystem. When flux data are supplied, the flux distribution is projected onto the 
metabolic network. The edge thickness is proportional to the intensity of the flux. By 
default, the edge thickness is rescaled to be between 0 and 1. However, the flux 
distribution may skew towards a specific extremely strong flux or range over several 
orders of magnitude. To enhance visibility, a user can project the fluxes logarithmically 
onto the network. The direction of the fluxes (forward or reverse) manifests in the 
direction of the corresponding edges. Flux distribution could be time-dependent. For 
example, when performing a dynamic metabolic simulation in COMETS, the magnitude 
and direction of each reaction flux may change over time. The flux change, e.g., from the 
forward direction to the reverse direction, of certain biochemical reactions at specific 
time points may have important biological meaning. Therefore, when a time-series flux 
distribution is provided, Dynamic Flux Visualization is automatically activated. A user can 
choose to examine the network (with its projected flux data) at various time points or at 
time 0 – the initial condition without any flux data. A slider allows the user to specify the 
time point he/she is interested in. The flux of exchange reactions can also be visualized 
as a special larger node that contains a flux vs. time profile graph with a small black 
triangle highlighting the time point at which the entire network is currently being 
visualized. Additionally, our platform can display the dynamic network as an animation. 
This time-series animation provides a visually intuitive way to examine the flux change in 
the network. The resulting dynamic network can be exported as an animated GIF file 
that can be easily shared with other researchers. 
4.2.3 Data integration 
The visualization of the metabolic model is developed on top of the VisANT platform. 
VisANT has a long history in biomedical research and is one of the most popular tools 
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for building and analyzing biological networks. Initially focused on the interaction network 
between bio-molecules in its first release (43), VisANT gradually expanded its scope to 
the fields of systems biology, systems pharmacology, and translational science (44–47), 
as well as to the integrated knowledge of diseases, therapies and drugs(48). The brain 
of VisANT is Predictome, a content-rich biological database that routinely fetches 
updated biological data from major public databases including Entrez Gene(49), 
KEGG(50) and BioGRID (51) among others. This supporting information is immediately 
available to the user when a biological network is opened in VisANT. 
For the visualization of metabolic networks, we added an integration of the KEGG 
reaction and compound databases, and the Enzyme Commission hierarchy. VisANT 
built-in functions such as Exploratory Navigation and Hierarchy Explorer natively support 
this newel added metabolic knowledge. Exploratory Navigation is one of the unique 
functions of VisANT. Beginning with a network element (a metabolite or a reaction, for 
example) of interest, the user can explore the elements associated with it using step-by-
step queries. In a metabolic network, it provides a natural way for a user to step through 
the reactions and metabolites associated with their element of interest. Hierarchy 
Explorer is a tree structure representation of hierarchical data such as GO Terms and 
the EC hierarchy. The EC hierarchy in Hierarchy Explorer not only provides a convenient 
way to explorer enzyme classification but is searchable and allows users to easily create 
new network elements such as reaction nodes by drag-and-drop one or more element(s) 
(that is, EC numbers) from Hierarchy Explorer to the workspace.  
In general, the gene and protein information can be omitted from a metabolic model, 
particularly when running a FBA-like simulation. Due to the nature of the integrated data 
74 
 
in VisANT, a user can attach gene information as well as linkages to other biological 
knowledge to an existing metabolic network if a proper (and standard) identifier has 
been used in the network. The metagraph capability allows the data to be analyzed from 
different perspectives with appropriate network transformation functions; therefore, the 
integration of other data such as the regulatory network, signaling network or expression 
data provides several new possibilities for future study. 
4.2.4 Comparative analysis 
VisANT 5.0 supports two types of comparative visualization: the flux distribution under 
different (i) conditions and (ii) locations (when spatial information is supplied). There is 
no limit to the number of inputs that can be visualized in VisANT. A user can compare 
multiple simulation results within a single metabolic network. When performing a 
comparative visualization, each edge is divided into several segments with different 
colors representing the flux of the corresponding conditions (or locations), and the 
thickness of each segment being proportional to the amount of flux. A toy example is 
shown in Figure 4-2 wherein the edge is divided into two segments: red and blue. Each 
segment represents the flux in a corresponding condition or location. If a user wants to 
compare only two conditions or locations, he/she can choose to show the different fluxes 
under two different conditions/locations on the edges. In this mode, the edge thickness is 
proportional to the normalized flux difference. 
 
Figure 4-2. A toy example of comparative analysis.  
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4.2.5 Support data format 
4.2.5.1 COMETS platform 
COMETS is a newly developed simulation platform developed by Prof. Segre’s group. 
Unlike traditional FBA, which is used to study the metabolic flux of a specific model in a 
particular steady state, COMETS extends the dynamic FBA (dFBA) to make it possible 
for researchers to study the spatial- and temporal- dynamics of a microbial community. 
Using the COMETS platform, a researcher can simulate a microbial ecosystem in a 
complex environment at gnome-scale resolution. COMETS is freely available at 
http://comets.bu.edu 
The inputs to COMETS are a set of genome scale metabolic modes, named Model Files, 
and a Layout File, which defines the model’s spatial distribution at the initial state, the 
composition of the extracellular media, and other constraints for the simulation. The 
model world is constructed based on these inputs. The output is a set of data matrices 
with the metabolic flux distribution. In collaboration with VisANT, a special file, named 
COMETS Manifest file, will automatically be generated after each simulation. This file 
specifies all the files and parameters required by VisANT in a computer readable format, 
thus providing a convenient shortcut for users who want to visualize their simulation 
results as metabolic networks in VisANT. 
Virtually, all COMETS file formats are support by VisANT. The most straightforward way 
to construct a dynamic ecosystem-level metabolic network in VisANT is through the 
COMETS Manifest file. In addition, a user can import either an individual model file to 
analyze the metabolic network of a single organism or a layout file only (without flux 
distribution) to examine all the possible metabolites interactions in the model world. 
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4.2.5.2 Other community standard file formats 
As a general biological network analysis platform, VisANT aims to support community 
standard file formats. Unfortunately, there is still no widely accepted file format for 
ecosystem-level metabolic network data. To provide broad support to the scientific 
community, VisANT supports SBML, the standard data interchange format used for 
models in Systems Biology. A metabolic network can be built by opening a SBML file in 
VisANT. In addition, if a user's flux data is not in COMTES output format, the user can 
convert the data into a simple tab-delimited format and then compile a user-defined 
manifest file to construct a complex metabolic network. Details on this file format are 
provided at http://visant.bu.edu 
 
4.3 Case Studies 
To demonstrate the effectiveness and potential of our metabolic network visual analytic 
platform, we examined two ecosystem-level metabolic networks from two different 
microbial consortiums.  
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4.3.1 Visualization of cross-feeding in a two-species microbial consortium 
 
Figure 4-3. Visualization of cross-feeding in a two-species microbial consortium without 
flux distribution 
 An E. coli-S. enterica synthetic consortium was used as a benchmark to evaluate the 
ability of COMETS to predict the qualitative behaviors of a microbial community(52). In 
our first case study, we used this consortium as an example and performed a visual 
analysis on it. This microbial consortium contains two species -Salmonella enterica 
serovar Thyphimurium str. LT2 and Escherichia coli K12 metB mutant -growing in a 
lactose minimal medium. This genetically modified E. coli strain cannot synthesize 
methionine and relies upon a partner in its community to satisfy its demand for 
methionine. On the other hand, in lactose medium, S. enterica cannot directly utilize 
lactose and must obtain carbon from a by-product of a partner its community. This 
consortium was extensively studied in previous work. The experimental test concluded 
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that neither species was able to grow alone in a lactose minimal media. However, when 
they were placed together to form a small community, the growth of both species was 
observed in lactose minimal media. 
An in silico experiment of this microbial consortium using the COMETS platform drew 
the same conclusion. By default, COMETS displays a series of images showing 
snapshots of colony at particular time points after running a simulation. It would be 
useful for a user to determine the status (growth or not, for instance) of a specific 
species inside the community. The detailed flux data is stored as a huge numerical 
matrix in a separate file and requires a certain level of programming skills to interpret the 
results. Our newly developed features in VisANT, which is capable of visualizing 
ecosystem-level metabolic network, enables one to easily examine the underlying 
metabolic exchanges and capture the findings mentioned above in lactose minimal 
media. To investigate this consortium from a network perspective, users can import its 
COMETS Manifest file, which is automatically created by the COMETS platform, into 
VisANT. Detailed instructions on how to open COMETS files are provided in 
http://visant.bu.edu. For this simulation, we used a 2D 1-by-1 grid to represent the model 
world, and we wanted to project the flux distribution happening in this tiny spot onto the 
resulting metabolic network. After applying Symbiotic Layout and manual adjustment, 
Figure 4-3 shows the network at time point 0 - the model world defined in the layout file - 
with no flux projection. This plot conveys no flux information, and the direction of each 
edge is determined by the constraints of each model or that of the model world. For 
example, a reaction that can proceed in either the forward or reverse direction has 
arrows on both sides of its connected edges. This plot provides an overview of the entire 
ecosystem. Additionally, it helps users examine the simulation’s setup and identify 
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potential problems in the model world prior to starting the simulation. Figure 4-4 shows 
the metabolic network behind this two-species consortium at time 13. To reduce the 
amount of data and irrelevant information displayed on the network, low intensity fluxes 
and highly connected cofactors such as ATP are hidden from the output network. The 
resulting network contains three gray nodes indicating the nutrient cross-feeding 
dependencies of E. coli and S. enterica. We can see that the carbon source of S. 
enterica, acetate (labeled as ac[e] on the network), is a by-product of E. coli. Similarly, E. 
coli obtains its essential methionine (met-L[e] on the network) from S. enterica. Another 
interesting fact at this particular time point is that the exchange of galactose (gal[e] on 
the network) also seems to be significant. This is testable prediction that has the 
potential to lead to biologically interesting studies. 
 
Figure 4-4. Visualization of cross-feeding in a two-species microbial consortium with flux 
distribution 
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4.3.2 Metabolic interactions of the microbial community in the human gut 
In the previous case study, we demonstrated that our visual analysis approach has the 
capability to highlight biologically relevant events in a two-species community. However, 
real life takes place in a highly complex environment. In reality, a “simple” microbial 
community can include several species. COMETS and VisANT can process a complex 
ecosystem - for example, a ten-species microbial consortium in a 3D grid - in one 
simulation. In our next case study, we performed a visual analysis of a multi-species 
microbial community in the human gut. 
We constructed an in silico microbial ecosystem containing six organisms, including C. 
difficile, B. fragilis, L. acidophilus, H. pylori, B. Longum, and E. coli. They represent the 
most abundant microbes in the human gut. Their metabolic modes were downloaded 
from DOE Kbase and converted into COMETS model files. We then ran a COMETS 
simulation with the six model organisms in a minimal D-glucose medium to study the 
exchange of metabolites in the community. 
The resulting network is shown in Figure 4-5. To simplify the network for clear viewing, 
we hide all the high degree metabolites and low flux reactions from the network. By 
default, the Symbiotic Layout, places all the model metanodes in a circular layout when 
the number of models in the community is greater than two. Metabolites that are 
transported in/out by more than one model are placed in the inner circle; metabolites that 
are only associated with one model are placed next to their corresponding models. 
Metabolites that are not utilized by any model are placed at the bottom of the screen. 
Due to space limitations, these uninformative metabolites are not displayed in Figure 4-5. 
In addition to showing interactions, the default layout also shows the internal metabolic 
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network of each model. Because the complexity of the resulting network may reduce its 
readability, one can transform the network into a bipartite graph by collapsing all the 
model metanodes. As shown in Figure 4-6, this compact representation helps users 
study the nutrient exchange between models and understands the relationships between 
community members of the ecosystem.
 
Figure 4-5. Visualization of the metabolic interactions in the human gut 
82 
 
 
Figure 4-6. A compact representation of the same network shown in the Figure 4-5 
An in-depth look at this ecosystem’s metabolic network reveals several interesting facts. 
For example, most models use glucose as their primary carbon source except B. fragilis 
and H. pylori. For B. fragilis, this may be due to incomplete knowledge in its metabolic 
model, which is typically a result of error-prone gap-filling during the metabolic model 
construction step. However, H. pylori updates a significant amount of proline, which has 
been reported to be important in H. pylori stomach colonization in other study(53, 54). 
Another interesting observation concerns the exchange of galactose in the community. 
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Galactose is a by-product of B. longum but was taken up by C. difficile and E. coli. A 
recently published study provides evidence to support this type of activates in B. 
longum(55). 
4.4 Conclusions 
We present a new strategy to examine complex ecosystem-level metabolic networks. By 
transforming numerical data matrices generated by simulations programs into human 
readable network graphs, researches can perform visual data analysis using our newly 
developed data analysis platform. The underlying nutrition exchanges in a community 
are represented by a dynamic network. Several existing network analysis tools can be 
applied to further understand the community of interest. An ecosystem-level network 
comprised of multiple genome-scale metabolic networks is highly complex; therefore, we 
have developed several tools and visualization strategies to reduce network complexity 
and emphasize the biologically interesting subnetworks of metabolic networks. In 
conjunction with ecosystem-level simulation platforms such as COMETS, researchers 
can use VisANT to construct in silico microbial communities and examine their 
community behavior in a quantitative manner.  
In this chapter, we demonstrated the functionality of our framework with two microbial 
communities. However, our framework is not limited to microbial communities. If 
corresponding simulation models are available, one can investigate non-microbe to 
microbe (for example, host and pathogen) or even cell to cell (for example, cancer and 
normal tissue) interaction using our platform. In addition, supplementary information 
such as gene expression and regulation data can be added to enrich the metabolic 
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networks in VisANT. The resulting heterogeneous networks provide several areas of 
potential future study for biologists.   
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Appendices 
APPENDIX A 
Protein 
Name Type Nullable Unique Description 
ProteinGI Integer No  Protein GI 
TaxId Integer    
GeneId Integer   Entrez Gene ID 
Name varchar(400)    
HasStructure smallint   0: no structure information 
1: has structure in PDB 
AddDate date no  default: current_date() 
LastModified timestamp no  default: current_timestampe() 
IsInCluster smallint   default:0 
0: not in protein cluster database 
1: in protein cluster database 
ReplacedBy integer yes  Replaced Protein GI: not null only if this 
record was replaced by the other record 
Primary Key:ProteinGI 
Indexes: 
 
● "pk_proteingi" PRIMARY KEY, btree ("ProteinGI") 
● "idx_protein_geneid" btree ("GeneId") 
● "idx_protein_proteingi_geneid" btree ("ProteinGI", "GeneId") 
Foreign-key constraints: 
● "fk_geneid_2_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
Referenced by: 
● TABLE ""Protein_ProteinCluster"" CONSTRAINT "fk_proteingi_protein" FOREIGN KEY 
("ProteinGI") REFERENCES "Protein"("ProteinGI") 
Triggers: 
● update_lastmodified_protein BEFORE UPDATE ON "Protein" FOR EACH ROW EXECUTE 
PROCEDURE update_lastmodified_column() 
● update_name_fulltextsearchforgene AFTER INSERT OR DELETE OR UPDATE ON "Protein" FOR 
EACH ROW EXECUTE PROCEDURE update_text_in_fulltextsearchforgene_on_protein() 
 
Tax 
Name Type Nullable Unique Description 
TaxId Integer No  NCBI Taxonomy Id 
Name varchar(200)   Taxonomy Name 
Kegg_abb varchar(5) Yes  KEGG abbreviation 
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Primary Key:TaxId 
Indexes: 
● "pk_taxid" PRIMARY KEY, btree ("TaxId") 
Referenced by: 
● TABLE ""Gene"" CONSTRAINT "fk_taxid_tax" FOREIGN KEY ("TaxId") REFERENCES 
"Tax"("TaxId") 
TABLE ""FullTextSearchForTax"" CONSTRAINT "fk_taxid_tax" FOREIGN KEY ("TaxId") REFERENCES 
"Tax"("TaxId") 
 
ProteinCluster 
Name Type Nullable Unique Description 
ClusterId Integer   Cluster Id in Protein Clusters Database 
ClusterAcc Char(11)   Cluster Accession Number in Protein 
Cluster Dtabase 
Definition Char(300)   Cluster Name 
ECNumber Char(10)   Enzyme commision number 
Status smallint   The level of curation for curated clusters 
● 1 = Provisional (minimal 
curation) 
● 2 = Validated (moderate 
curation) 
● 3 = Reviewed (extensive 
curation) 
COGGroup Char(200)   NCBI COG group 
N_Proteins int   Number of proteins in this cluster 
ConserverdIn varchar(100)    
N_Organisms int   Number of organisms in this cluster 
DomainDes varchar(300)    
LC_Definition varchar(300)   lower("Definition") 
IsCuratd smallint   0: non-curated cluster 
1: curated cluster 
SciBayStatus real   <0 (-1) : black 
1: green 
2: (2a)blue 
2.5: (2b)blue 
ModelOrganCount int   0: this cluster does not contain genes in 
the model organisms 
1: this cluster contains genes in the 
model organisms 
PhylScore double 
precision 
  Phylogenetic spread score: smaller is 
better 
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N_phyla int    
N_class int    
N_order int    
N_genera int    
N_species int    
N_strains int    
HasStructure smallint   1: this cluster contains at least one gene 
which has structure information in PDB 
N_gold int   Number of gold genes in this cluster 
N_green int   Number of green genes in this cluster 
N_blue int   Number of blue genes in this cluster 
N_black int   Number of black genes in this cluster 
Primary Key:ClusterId 
Indexes: 
● "pk_pclusterid" PRIMARY KEY, btree ("ClusterId") 
● "idx_clusteracc" btree ("ClusterAcc") 
● "idx_iscuratd" btree ("IsCuratd") 
Referenced by: 
● TABLE ""Cluster2Phylogenetic"" CONSTRAINT "Cluster2Phylogenetic_ClusterId_fkey" FOREIGN 
KEY ("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
● TABLE ""ClusterAvgBranch"" CONSTRAINT "fk_clusterid_ proteincluster" FOREIGN KEY 
("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
● TABLE ""SimpleScore"" CONSTRAINT "fk_clusterid_2_proteincluster" FOREIGN KEY ("ClusterId") 
REFERENCES "ProteinCluster"("ClusterId") 
● TABLE ""ProteinCluster_PubMed"" CONSTRAINT "fk_clusterid_2_proteincluster" FOREIGN KEY 
("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
● TABLE ""Protein_ProteinCluster"" CONSTRAINT "fk_clusterid_2_proteincluster" FOREIGN KEY 
("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
● TABLE ""ProteinCluster2TaxId"" CONSTRAINT "fk_clusterid_proteincluster" FOREIGN KEY 
("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
● TABLE ""ProteinCluster_CDD"" CONSTRAINT "fk_clusterid_proteincluster" FOREIGN KEY 
("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
● TABLE ""ClusterMinDistToExpGene"" CONSTRAINT "fk_clusterid_proteincluster" FOREIGN KEY 
("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
● TABLE ""FullTextSearch"" CONSTRAINT "fk_fulltextsearch_clusterid" FOREIGN KEY ("ClusterId") 
REFERENCES "ProteinCluster"("ClusterId") 
TABLE ""ProteinCluster2Img"" CONSTRAINT "fk_proteincluster_clusterid" FOREIGN KEY ("ClusterId") 
REFERENCES "ProteinCluster"("ClusterId") 
 
Protein_ProteinCluster 
Name Type Nullable Unique Description 
ClusterId Integer   Cluster Id in Protein Clusters Database 
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ProteinGI Integer   Protein GI 
Primary Key: 
Indexes: 
● "pk_pclusterid_proteingi" PRIMARY KEY, btree ("ProteinGI", "ClusterId") 
● "idx_proteinproteincluster_clusterid" btree ("ClusterId") 
● "idx_proteinproteincluster_proteingi" btree ("ProteinGI") 
Foreign-key constraints: 
● "fk_clusterid_2_proteincluster" FOREIGN KEY ("ClusterId") REFERENCES 
"ProteinCluster"("ClusterId") 
"fk_proteingi_protein" FOREIGN KEY ("ProteinGI") REFERENCES "Protein"("ProteinGI") 
 
ProteinCluster2Img 
Name Type Nullable Unique Description 
ClusterId Integer no   
Type varchar(20) no   
FileName varchar(30) no   
Primary Key: 
Indexes: 
Foreign-key constraints: 
"fk_proteincluster_clusterid" FOREIGN KEY ("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
 
ProteinCluster2TaxId 
Name Type Nullable Unique Description 
ClusterId Integer    
TaxId Integer    
Primary Key: 
Indexes: 
● "pk_clusterid_taxid" PRIMARY KEY, btree ("ClusterId", "TaxId") 
● "idx_proteincluster2taxid_taxid" btree ("TaxId") 
● "idx_proteincluster2taxid_taxid_clusterid" btree ("TaxId", "ClusterId") 
Foreign-key constraints: 
"fk_clusterid_proteincluster" FOREIGN KEY ("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
 
ProteinCluster_CDD 
Name Type Nullable Unique Description 
ClusterId Integer    
PSSMId Integer    
Primary Key: 
Indexes: 
● "idx_proteinclustercdd_clusterid" btree ("ClusterId") 
Foreign-key constraints: 
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"fk_clusterid_proteincluster" FOREIGN KEY ("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
 
Gene2ExtLink 
Name Type Nullable Unique Description 
GeneId Integer    
DB varchar(10)   External Database Name 
ID varchar(10)   Id in the other database 
Primary Key: 
Indexes: 
● "idx_gene2extlink_geneid" btree ("GeneId") 
Foreign-key constraints: 
"fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
 
Gene2ExpValidated 
Name Type Nullable Unique Description 
GeneId Integer    
Annotation varchar(255)    
Evidence varchar(255)    
Refs varchar(255)   A list of pubmed id separated by "|" 
Source varchar(50)    
Type smallint   0:Green 
1:Gold 
AddDate date no  default: current_date() 
LastModified timestamp no  default: current_timestampe()    
SourceId int    
G2ExpId int no yes  
IsExpValidated int   0: GreenB 
1: GreenA or Gold 
Primary Key:  
Indexes: 
● "Gene2ExpValidated_G2ExpId_key" UNIQUE, btree ("G2ExpId") 
● "fki_sourceid_source" btree ("SourceId") 
● "idx_gene2expvalidated_geneid" btree ("GeneId") 
Foreign-key constraints: 
● "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
● "fk_sourceid_source" FOREIGN KEY ("SourceId") REFERENCES "Source"("SourceId") 
Triggers: 
● update_annotation_fulltextsearchforgene AFTER INSERT OR DELETE OR UPDATE ON 
"Gene2ExpValidated" FOR EACH ROW EXECUTE PROCEDURE 
update_text_in_fulltextsearchforgene_on_genetoexp() 
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update_lastmodified_gene2expvalidated BEFORE UPDATE ON "Gene2ExpValidated" FOR EACH ROW 
EXECUTE PROCEDURE update_lastmodified_column() 
 
Cluster2Phylogenetic 
Name Type Nullable Unique Description 
ClusterId Integer    
TaxId Integer    
Phylumid Integer    
Species_is int    
OrderWithinCluster int    
Primary Key: 
Indexes: 
● "idx_cluster2phylogenetic" btree ("ClusterId", "TaxId") 
Foreign-key constraints: 
"Cluster2Phylogenetic_ClusterId_fkey" FOREIGN KEY ("ClusterId") REFERENCES 
"ProteinCluster"("ClusterId") 
 
ClusterAvgBranch 
Name Type Nullable Unique Description 
ClusterId Integer    
ProteinGI Integer    
BranchLength double 
precision 
   
Primary Key: 
Indexes: 
● "idx_clusteravgbranch" btree ("ClusterId", "ProteinGI") 
Foreign-key constraints: 
"fk_clusterid_ proteincluster" FOREIGN KEY ("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
 
ClusterMinDistToExpGene 
Name Type Nullable Unique Description 
ClusterId int    
ProteinGI int    
GreenGeneGI int    
Distance double 
precision 
   
Primary Key:  
Indexes: 
● "pk_clustermindisttoexpgene_clusterid_proteingi" PRIMARY KEY, btree ("ClusterId", 
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"ProteinGI") 
Foreign-key constraints: 
"fk_clusterid_proteincluster" FOREIGN KEY ("ClusterId") REFERENCES "ProteinCluster"("ClusterId") 
 
CDD 
Name Type Nullable Unique Description 
PSSMId Integer   PSSM ID 
PSSMAcc varchar(20)   PSSM Accession 
ShortName varchar(60)   Shot name of CDD 
Description text    
Primary Key: PSSMId 
Index: 
"CDD_pkey" PRIMARY KEY, btree ("PSSMId") 
 
Gene 
Name Type Nullable Unique Description 
GeneId int no yes value > 0: Entrez Gene ID 
value < 0: pseudo gene id (negative 
value of its protein gi) 
GeneSymbol varchar(50)   Gene Symbol 
TaxId Integer   Taxonomy ID 
LocusTag varchar(30)   Locus Tag 
State int   Replaced Gene Id 
Not null if this gene was replaced by the 
other gene. 
Alias varchar(1000)   Other synonyms separated by '|' 
Type varchar(30)    
Description varchar(2048)    
SciBayStatus smallint   0: gold 
1: green 
2: blue 
3: black 
HasStructure smallint   0: no structure information 
1: has structure information in PDB 
AddDate date no  default: current_date() 
LastModified timestamp no  default: current_timestamp() 
IsInCluster smallint   default: 0 
0: not in NCBI protein cluster database 
1: in NCBI protein cluster database 
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Description_tsv tsvector    
IsInModelOrganism smallint   default: 0 
0: not in the model organisms 
1: in the model organisms 
IsExpValidated int   default: 0 
0: not exp. validated 
1: exp. validated 
(not use and update this fields) 
Primary Key: GeneId 
Indexes: 
● "pk_geneid" PRIMARY KEY, btree ("GeneId") 
● "idx_description" btree ("Description") 
● "idx_desctsv" gin ("Description_tsv") 
● "idx_gene_taxid" btree ("TaxId") 
● "idx_genesymbol" btree ("GeneSymbol") 
● "idx_isIncluster_scibaystatus" btree ("SciBayStatus", "IsInCluster") 
● "idx_locustag" btree ("LocusTag") 
Foreign-key constraints: 
● "fk_taxid_tax" FOREIGN KEY ("TaxId") REFERENCES "Tax"("TaxId") 
Referenced by: 
● TABLE ""Gene2Interaction"" CONSTRAINT "fk_geneid1_gene" FOREIGN KEY ("GeneId_1") 
REFERENCES "Gene"("GeneId") 
● TABLE ""Gene2Interaction"" CONSTRAINT "fk_geneid2_gene" FOREIGN KEY ("GeneId_2") 
REFERENCES "Gene"("GeneId") 
● TABLE ""Protein"" CONSTRAINT "fk_geneid_2_gene" FOREIGN KEY ("GeneId") REFERENCES 
"Gene"("GeneId") 
● TABLE ""Gene2Go"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES 
"Gene"("GeneId") 
● TABLE ""Gene2RefSeq"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES 
"Gene"("GeneId") 
● TABLE ""Gene2KeggPathway"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") 
REFERENCES "Gene"("GeneId") 
● TABLE ""FullTextSearchForGene"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") 
REFERENCES "Gene"("GeneId") 
● TABLE ""Gene2Blast_GreenGene"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") 
REFERENCES "Gene"("GeneId") 
● TABLE ""Gene2ExtLink"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES 
"Gene"("GeneId") 
● TABLE ""Gene2Propagation"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") 
REFERENCES "Gene"("GeneId") 
● TABLE ""Gene2Reaction"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") 
REFERENCES "Gene"("GeneId") 
● TABLE ""Gene_CDD"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES 
"Gene"("GeneId") 
● TABLE ""Gene_Pfam"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES 
"Gene"("GeneId") 
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● TABLE ""Gene2Alias"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES 
"Gene"("GeneId") 
● TABLE ""Gene2Prediction"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") 
REFERENCES "Gene"("GeneId") 
● TABLE ""Gene2ExpValidated"" CONSTRAINT "fk_geneid_gene" FOREIGN KEY ("GeneId") 
REFERENCES "Gene"("GeneId") 
Triggers: 
● update_description_fulltextsearchforgene AFTER INSERT OR DELETE OR UPDATE ON "Gene" 
FOR EACH ROW EXECUTE PROCEDURE update_text_in_fulltextsearchforgene_on_gene() 
● update_descriptiontsv_gene BEFORE INSERT OR UPDATE ON "Gene" FOR EACH ROW EXECUTE 
PROCEDURE tsvector_update_trigger('Description_tsv', 'pg_catalog.english', 'Description') 
update_lastmodified_gene BEFORE UPDATE ON "Gene" FOR EACH ROW EXECUTE PROCEDURE 
update_lastmodified_column() 
 
Gene2Alias 
Name Type Nullable Unique Description 
GeneId Integer   Gene Id 
Alias varchar(30)   Alias Name 
Primary Key: 
Indexes: 
● "idx_gene2alias_alias" btree ("Alias") 
● "idx_gene2alias_lower_alias" btree (lower("Alias"::text)) 
Foreign-key constraints: 
"fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
 
Gene2Blast_GreenGene 
Name Type Nullable Unique Description 
GeneId Integer   Gene Id 
GreenGeneId Integer   Gene Id of green/gold gene 
%_identity double 
precision 
   
E_val varchar(20)    
BitScore double 
precision 
   
AddDate date no  default: current_date() 
LastModified timestamp no  default: current_timestampe() 
IsTop smallint   default: 0 
0: not top one hit 
1: top 1 hit 
DispOrder int no   
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Primary Key: 
Indexes: 
● "idx_gene2blast_greengene" btree ("GeneId") 
Foreign-key constraints: 
● "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
Triggers: 
update_lastmodified_gene2blast_greengene BEFORE UPDATE ON "Gene2Blast_GreenGene" FOR EACH 
ROW EXECUTE PROCEDURE update_lastmodified_column() 
 
Gene2Go 
Name Type Nullable Unique Description 
GeneId Integer   Gene Id 
SciBayGoId Integer    
Evidence varchar(4)   GO evidence code 
Qualifier varchar(20)   GO Qualifier 
Date varchar(8)    
AssignedBy varchar(100)    
Category smallint   1: Biological Process 
2: Molecular Function 
3: Cellular Component 
Reference varchar(150)    
Primary Key: 
Indexes: 
● "idx_gene2go_geneid" btree ("GeneId") 
Foreign-key constraints: 
● "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
"fk_scibaygoid_goterm" FOREIGN KEY ("SciBayGoId") REFERENCES "GoTerm"("SciBayGoId") 
 
GoTerm 
Name Type Nullable Unique Description 
SciBayGoId Integer    
GoTerm varchar(200)   GO Term 
Category smallint   1: Biological Process 
2: Molecular Function 
3: Cellular Component 
GoAcc varchar(255)   GO Accession 
Primary Key: 
Indexes: 
● "pk_goacc" PRIMARY KEY, btree ("SciBayGoId") 
Foreign-key constraints: 
TABLE ""Gene2Go"" CONSTRAINT "fk_scibaygoid_goterm" FOREIGN KEY ("SciBayGoId") REFERENCES 
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"GoTerm"("SciBayGoId") 
 
Gene2Interaction 
Name Type Nullable Unique Description 
GeneId_1 int    
GeneId_1 int    
Direct smallint   0: no direction 
1: gene 1 -> gene 2 
2: gene 2 -> gene 1 
Method varchar(100)    
Weight real   Weight of edge or confidence 
Comment varchar(255)   default: null 
Source varchar(50)    
PredictionId int    
Primary Key: 
Indexes: 
● "idx_gend2interaction_predictionid" btree ("PredictionId") 
Foreign-key constraints: 
● "fk_geneid1_gene" FOREIGN KEY ("GeneId_1") REFERENCES "Gene"("GeneId") 
● "fk_geneid2_gene" FOREIGN KEY ("GeneId_2") REFERENCES "Gene"("GeneId") 
"fk_prediction_predictionid" FOREIGN KEY ("PredictionId") REFERENCES "Prediction"("PredictionId") 
 
Gene2KeggPathway 
Name Type Nullable Unique Description 
GeneId int no   
PathwayId int no   
Primary Key: (GeneId, PathwayId) 
Indexes: 
● "pk_gene2keggpathway" PRIMARY KEY, btree ("GeneId", "PathwayId") 
Foreign-key constraints: 
● "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
"fk_pathwayid_keggpathway" FOREIGN KEY ("PathwayId") REFERENCES "KeggPathway"("PathwayId") 
 
KeggPathway 
Name Type Nullable Unique Description 
PathwayId int no  default: nextval('keggpathway_id_seq') 
Entry varchar(9)   KEGG Entry 
Name varchar(150)    
TaxId int   (not use) 
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Primary Key: PathwayId) 
Indexes: 
● "pk_pathwayid" PRIMARY KEY, btree ("PathwayId") 
Foreign-key constraints: 
TABLE ""Gene2KeggPathway"" CONSTRAINT "fk_pathwayid_keggpathway" FOREIGN KEY ("PathwayId") 
REFERENCES "KeggPathway"("PathwayId") 
 
 
Gene2Prediction 
Name Type Nullable Unique Description 
GeneId Integer no  Gene Id 
Annotation varchar(255) no   
Evidence varchar(255)   default: null 
Refs varchar(20)   default: null 
A list of pubmed id separated by "|" 
Source varchar(50) no   
PredictionId int    
Primary Key: 
Indexes: 
● "idx_gend2prediction_predictionid" btree ("PredictionId") 
● "idx_gene2prediction" btree ("GeneId") 
Foreign-key constraints: 
● "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
"fk_prediction_predictionid" FOREIGN KEY ("PredictionId") REFERENCES "Prediction"("PredictionId") 
 
 
Gene2Propagation 
Name Type Nullable Unique Description 
GeneId Integer no  Gene Id 
GreenGeneId Integer no  Gene Id of green/gold gene 
%_identity double 
precision 
   
QueryCoverage double 
precision 
   
TargetCoverage double 
precision 
   
E_val varchar(20)    
BitScore double 
precision 
   
SharedDomain int    
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Primary Key: 
Indexes: 
● "fki_geneid_gene" btree ("GeneId") 
Foreign-key constraints: 
"fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
 
Gene2Reaction 
Name Type Nullable Unique Description 
GeneId int no   
ReactionId int no   
Primary Key: 
Indexes: 
● "fki_reactionid_reaction" btree ("ReactionId") 
● "idx_gene2reaction" btree ("GeneId") 
Foreign-key constraints: 
● "fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
"fk_reactionid_reaction" FOREIGN KEY ("ReactionId") REFERENCES "Reaction"(id) 
 
Reaction 
Name Type Nullable Unique Description 
id int   default: nextval('reaction_id_seq') 
sname varchar(20)   short name of reaction 
formula varchar(200)    
name varchar(200)   full name of the reaction 
pathway varchar(100)    
Primary Key: 
Indexes: 
● "Reaction_id_key" UNIQUE, btree (id) 
Foreign-key constraints: 
TABLE ""Gene2Reaction"" CONSTRAINT "fk_reactionid_reaction" FOREIGN KEY ("ReactionId") 
REFERENCES "Reaction"(id) 
 
Gene2RefSeq 
Name Type Nullable Unique Description 
GeneId int no   
Status varchar(20)   short name of reaction 
RNAAcc varchar(20))   RefSeq accession of RNA 
RNAGI int   RNA GI 
ProteinAcc varchar(20)   RefSeq accession of Protein 
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ProteinGI int   Protein GI 
GenomeAcc varchar(20)   RefSeq accession of genome 
GenomeGI int   Genome GI 
Primary Key: 
Indexes: 
● "idx_geneid" btree ("GeneId") 
● "idx_proteinacc" btree ("ProteinAcc" varchar_pattern_ops) 
Foreign-key constraints: 
"fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
 
Gene2VisantExpIntCnt 
Name Type Nullable Unique Description 
GeneId int no   
Count int no   
Primary Key: 
Indexes: 
"Gene2VisantExpIntCnt_pkey" PRIMARY KEY, btree ("GeneId") 
 
Gene_CDD 
Name Type Nullable Unique Description 
GeneId int no   
PSSMId int no   
Primary Key: 
Foreign-key constraints: 
"fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
 
Gene_Pfam 
Name Type Nullable Unique Description 
GeneId int no   
auto_pfamA int no   
Primary Key: 
Indexes: 
● "fki_auto_pfama_pfam" btree ("auto_pfamA") 
● "idx_gene_pfam_geneid" btree ("GeneId") 
Foreign-key constraints: 
● "fk_auto_pfama_pfam" FOREIGN KEY ("auto_pfamA") REFERENCES "Pfam"("auto_pfamA") 
"fk_geneid_gene" FOREIGN KEY ("GeneId") REFERENCES "Gene"("GeneId") 
 
Pfam 
Name Type Nullable Unique Description 
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auto_pfamA int no   
pfama_acc varchar(7) no  Pfam accesion 
pfama_id varchar(16) no  Pfam id 
Primary Key: auto_pfamA 
Indexes: 
● "Pfam_pkey" PRIMARY KEY, btree ("auto_pfamA") 
Referenced by: 
TABLE ""Gene_Pfam"" CONSTRAINT "fk_auto_pfama_pfam" FOREIGN KEY ("auto_pfamA") 
REFERENCES "Pfam"("auto_pfamA") 
 
PrioritizationScore 
Name Type Nullable Unique Description 
GeneId Integer   Gene ID 
PriorityTypeId INTEGER   PriorityTypeId 
Score REAL   Prioritization Score 
Primary Key: 
Index: 
 
Gene_Propagation 
Name Type Nullable Unique Description 
PropagationId Int   PropagationId 
GeneId Int   Target Gene Id 
ExpGeneId Int   Green/Gold Gene Id 
Annotation Int   Propagated Function 
%_identityWithExpGene double 
precision 
  Full length percent identity with 
gold/green gene 
%_identityWithTargetGe
ne 
double 
precision 
  Full length percent identity with target 
gen 
E_val varchar(20)   BLAST e-valu 
BitScore double   Bit score of the BLAST hit between the 
pair 
ShareDomain int   Number of domains shared  
ClusterInfoStatus int   the cluster relationship status of the 
propagated pair of genes 
-1:unknown 
0: identical 
1: related 
2: non-related 
Primary Key: 
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Index: 
"idx_expgeneid" btree ("ExpGeneId") 
 
Propagation2CDD 
Name Type Nullable Unique Description 
PropagationId int   PropagationId 
PSSMId int   domains that are shared by the pair of 
genes propagated. 
Primary Key: StateId 
Index: 
 
Propagation2GO 
Name Type Nullable Unique Description 
PropagationId int   PropagationId 
SciBayGoId int   GO Terms of the gold.green gene 
Primary Key: 
Index: 
 
ProteinCluster2SuperCluster 
Name Type Nullable Unique Description 
SuperClusterId varchar(10)    
ClusterId_1 int    
ClusterId_2 int    
Score double 
precision 
   
Primary Key: 
Index: 
 
Propagation2CDD 
Name Type Nullable Unique Description 
PropagationId int   PropagationId 
PSSMId int   domains that are shared by the pair of 
genes propagated. 
Primary Key: StateId 
Index: 
 
Gene2SourceOfPrediction 
Name Type Nullable Unique Description 
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GeneId int   Entrez GeneID 
Source int   ● 1: COMBREX conservative 
propagation algorithm 
● 2: Prediction submitted to 
COMBREX 
● 3: NCBI annotation 
● 4: NCBI Protein Clusters 
Primary Key: 
Index: 
 
Gene2EC 
Name Type Nullable Unique Description 
GeneId int   Entrez GeneID 
Source varchar(10)   ● NCBI 
● brenda 
0ECNumber varchar(12)   EC Number 
Primary Key: 
Index: 
 
Phenotype 
Name Type Nullable Unique Description 
PhenotypeId int no yes  
Phenotype character 
varying(128) 
   
Penetrance int    
Type                int   1=Predicted, 2=Experimental 
(deprecated: will be replaced by 
green/gold status) 
Reference character(64
) 
  not used - replaced by 
ProteinPhenotype2Reference 
PredictionGroupId int    
PredictionMethodId int    
EnvironmentTested text    
AdditionalInfo text    
Description text    
LocalIdentifier char(24)    
Primary Key: PhenotypeId 
Index:  
 "pk_pheno" PRIMARY KEY, btree ("PhenotypeId") 
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Phenotype2GO 
Name Type Nullable Unique Description 
PhenotypeId int no   
SciBayGoId int no   
Primary Key:  
Index:  
"p2go_unique" UNIQUE, btree ("PhenotypeId", "SciBayGoId") 
 
PhenotypeEncodedFunction 
Name Type Nullable Unique Description 
PhenotypeEncodedFunct
ionId 
int no   
Category char 
varying(5) 
no   
Description text    
Primary Key:  
Index: "PhenotypeEncodedFunction_pkey" PRIMARY KEY, btree ("PhenotypeEncodedFunctionId") 
 
 
Protein2Phenotype 
Name Type Nullable Unique Description 
ProteinGI int no   
PhenotypeId int no   
IsNaturalSequence boolean    
Sequence             text    
AdditionalInfo text    
ExpressionClass int   1=Knock out, 2=Knock in, 
3=Overexpression, 4=Wild type 
NCBI_DNA character 
varying(24) 
  NCBI identifier 
StartCoord character 
varying(24) 
  text to accomodate GenBank encoding 
StopCoord character 
varying(24) 
   
PhenotypeEncodedFunct
ionId 
int    
Primary Key:  
Index:  
103 
 
 "Protein2Phenotype_ProteinGI_PhenotypeId_key" UNIQUE, btree ("ProteinGI", 
"PhenotypeId") 
 "Protein2Phenotype_ProteinGI_PhenotypeId_idx" btree ("ProteinGI", "PhenotypeId") 
Foreign-key constraints: 
 "PhenotypeId" FOREIGN KEY ("PhenotypeId") REFERENCES "Phenotype"("PhenotypeId") 
 "Protein2Phenotype_ProteinGI_fkey" FOREIGN KEY ("ProteinGI") REFERENCES 
"Protein"("ProteinGI") 
 
ProteinPhenotype2Reference 
Name Type Nullable Unique Description 
ProteinGI int no   
PhenotypeId int no   
Reference character 
varying(20) 
  PMID for now 
ReferenceInfo text    
Primary Key:  
Index:  
"p2go_unique" UNIQUE, btree ("PhenotypeId", "SciBayGoId") 
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APPENDIX B  
Computational predictions can be submitted to COMBREX in one of the following file 
formats. Each file should contain a header (describing below) in the first two lines 
Header lines: 
* # Lab Name: This field contains the details of how a submitter wants to be identified. 
For example, as a lab name, email address, name of the Principal Investigator etc. 
* # Contact Email: An email id that can be used for corresponding with the group 
regarding successful receiving of predictions, notifications regarding incorrect file 
formats etc.  
Case 1: Predicting functions for a set of individual genes (associating genes with 
functions) 
The following fields should be separated by tabs. Every row represents a single 
prediction for a single protein. If a protein has multiple predictions, put them in separate 
rows. 
* Gene Identifier: This field can contain either the Entrez GeneID or NCBI RefSeq 
Protein GI. The field can only contain numerical values 
* Type of Identifier: This can be “0” for GeneID ; “1” for ProteinGI ; default is 0. This 
field can only contain numerical values 
* Prediction: This field contains the predicted function as a free text description. Limit up 
to 250 characters 
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GO/EC Number (optional): This field can contain either the GO term or the EC number 
corresponding to the predicted function (if available). GO terms must be in the format 
“GO:0005515” and EC numbers must be in format “EC:3.4.11.4”.  
Confidence Score (optional): This field contains the confidence value or the probability 
score of the protein having the particular prediction, normalized to a percentage score 
between 0 and 100. 
Evidence: This field contains evidence to the submitted prediction. For example: 
Prediction based on homology to gene “X” 
* Reference: This field contains the PMID (PubMed ID) of the paper that describes the 
method used for obtaining the particular prediction. For example: 20675471. This field 
can only contain numbers 
Links (optional): This is an optional field in case if there is extra information available as 
an external link. 
Case 2: Predicting Functional linkages between genes.  
The following fields should be present as columns separated by tab. Every row 
represents a single prediction for a protein. In the case, a protein has multiple 
predictions, put them in separate rows. 
*Identifier for Gene1: This field can contain either the Entrez GeneID or NCBI RefSeq 
Protein GI. The field can only contain numbers  
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*Identifier for Gene2: This field can contain either the Entrez GeneID or NCBI RefSeq 
Protein GI. The field can only contain numbers  
*Type of Identifier: This can be “0” for GeneID ; “1” for ProteinGI ; default is 0. This field 
can only contain numerical values 
Direction of Linkage (optional): This field contains numerical values depending on the 
direction of the linkage. The value is “0” if the direction of linkage is unknown. The value 
is “-1” if the direction of linkage is from Gene2 Gene1. The value is “1” if the direction of 
linkage is from Gene1 Gene2. Note: In cases, when the linkage is bi-directional, please 
output in 2 separate rows, one row indicating linkage from Gene1 –> Gene2 and the 
other row from Gene2 –> Gene1. 
Prediction (optional): This field contains the predicted function (if the protein set is 
involved in a common biochemical function) as a free text description. If the proteins are 
just linked together by a common process or reaction, this field can be left blank Limit up 
to 250  
GO/EC Number (optional): This field can contain either the GO term or the EC number 
corresponding to the predicted function (if prediction available). GO terms must be in the 
format “GO:0005515” and EC numbers must be in format “EC:3.4.11.4”. In the case that 
the proteins are just linked to one another by some common process/reaction, this field 
can be left blank. 
Confidence Score (optional): This field contains the confidence value or the probability 
score for the predicted linkage normalized to a percentage value between 0 and 100 
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Evidence (optional): This field contains evidence to the submitted linkage/prediction.  
*Reference: This field contains the PMID (PubMed ID) of the paper that describes the 
method used for obtaining the particular prediction. For example: 20675471. This field 
can only contain numbers 
Links (optional): This is an optional field in case if there is extra information available as 
an external link. 
Case 3: Gene Predicting Protein Cluster/Family 
The following fields should be present as columns separated by tab. Every row 
represents a single prediction for a protein. In the case, a protein has multiple 
predictions, put them in separate rows. 
* Gene Identifier: This field can contain either the Entrez GeneID or NCBI RefSeq 
Protein GI. The field can only contain numbers  
* Type Identifier: This can be “0” for GeneID ; “1” for ProteinGI ; default is 0. This field 
can only contain numerical values 
* Group Identifier: A numerical value identifying a particular group/cluster. For example: 
A number for Protein Cluster “PRK09604”, say 1 
Group Name (optional): A name for the particular group/cluster used for predicting 
function (if available). For example, Protein Cluster “PRK09604” 
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Group Description (optional): This field contains the predicted function of the group as 
a free text description. Limit up to 250 characters 
GO/EC Number (optional): This field can contain either the GO term or the EC number 
corresponding to the predicted function of the group (if available). GO terms must be in 
the format “GO:0005515” and EC numbers must be in format “EC:3.4.11.4”.  
Confidence Score (optional): This field contains the confidence score or the probability 
score for the predicted group membership normalized to a percentage value between 0 
and 100 
Evidence (optional): This field contains evidence to the submitted prediction. 
*Reference: This field contains the PMID (PubMed ID) of the paper that describes the 
method used for obtaining the particular prediction. For example: 20675471. This field 
can only contain numbers 
Links (optional): This is an optional field in case if there is extra information available as 
an external link. 
All fields marked by “*” are mandatory. Optional fields can be left blank if case of 
unavailability of information. 
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APPENDIX C 
ID Annotation Best BLAST hit 
7_7 Redoxin domain protein(Leptotrichia buccalis C-1013-b) Lebu_0054(e-value: 9e-
87) 
16_1 ribonuclease H(Polynucleobacter necessarius subsp. 
asymbioticus QLW-P1DMWA-1) 
rnhA(e-value: 1e-18) 
25_1 ATP synthase F1, epsilon subunit(Desulfovibrio 
desulfuricans subsp. desulfuricans str. ATCC 27774) 
Ddes_2189(e-value: 5e-
09) 
38_0 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_2039(e-value: 7e-
52) 
61_1 Lipoprotein spr(Cronobacter turicensis) spr(e-value: 4e-23) 
68_1 hypothetical protein(Cronobacter turicensis) Ctu_37530(e-value: 4e-
88) 
71_1 transfer protein(Bifidobacterium animalis subsp. lactis 
AD011) 
BLA_0430(e-value: 9e-19) 
72_0 putative ATP-dependent Clp protease, proteolytic 
subunit(Streptococcus suis 05ZYH33) 
SSU05_1551(e-value: 7e-
16) 
73_3 peptide chain release factor-like protein(Bacteroides 
fragilis NCTC 9343) 
prfH(e-value: 6e-06) 
88_0 polar amino acid ABC transporter ATP-binding 
protein(Synechococcus sp. JA-3-3Ab) 
CYA_0228(e-value: 1e-33) 
111_1 oxidoreductase(Rhodococcus erythropolis PR4) RER_50690(e-value: 1e-
10) 
118_1 Na+ transporting oxaloacetate decarboxylase beta 
chain(Streptococcus pyogenes MGAS10750) 
MGAS10750_Spy1053(e-
value: 9e-31) 
121_0 homoserine dehydrogenase(Thermomicrobium roseum 
DSM 5159) 
trd_0367(e-value: 2e-41) 
152_0 SNO glutamine amidotransferase(Leptotrichia buccalis C-
1013-b) 
Lebu_1507(e-value: 5e-
86) 
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156_0 MATE efflux family protein DinF, truncated(Streptococcus 
thermophilus CNRZ1066) 
str0947(e-value: 1e-29) 
207_1 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_0616(e-value: 9e-
57) 
243_1 uracil-DNA glycosylase(Clostridium difficile R20291) ung(e-value: 3e-61) 
255_0 predicted ORF(Lactobacillus rhamnosus Lc 705) LC705_01296(e-value: 6e-
21) 
273_0 binding-protein-dependent transport systems inner 
membrane component(Geobacillus sp. WCH70) 
GWCH70_0296(e-value: 
3e-47) 
309_0 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_1637(e-value: 7e-
102) 
313_0 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase(Clostridium thermocellum ATCC 
27405) 
Cthe_0973(e-value: 3e-
10) 
318_0 cell division protein FtsI/penicillin-binding protein 
2(Dictyoglomus thermophilum H-6-12) 
DICTH_0339(e-value: 3e-
11) 
328_1 transcriptional regulator, MarR family(Leptotrichia 
buccalis C-1013-b) 
Lebu_0428(e-value: 8e-
71) 
355_0 GTP-binding protein TypA/BipA(Streptococcus pyogenes 
MGAS2096) 
MGAS2096_Spy1275(e-
value: 7e-17) 
356_0 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_0216(e-value: 6e-
83) 
366_0 hypothetical protein(Pelotomaculum 
thermopropionicum SI) 
PTH_1502(e-value: 5e-07) 
372_1 FtsW/RodA/SpoVE family peptidoglycan biosynthesis 
protein(Desulfotomaculum reducens MI-1) 
Dred_0313(e-value: 4e-
17) 
376_0 glycosyltransferase(Clostridium thermocellum ATCC 
27405) 
Cthe_0209(e-value: 5e-
22) 
386_2 phage SPO1 DNA polymerase-related 
protein(Leptotrichia buccalis C-1013-b) 
Lebu_1116(e-value: 1e-
76) 
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421_2 UTP--glucose-1-phosphate uridylyltransferase 
protein(Nitrosomonas europaea ATCC 19718) 
galU1(e-value: 6e-19) 
421_5 DNA polymerase III, subunit alpha (dnaE)-like 
protein(Clostridium perfringens SM101) 
CPR_0339(e-value: 2e-91) 
441_1 chloride channel protein(Streptococcus equi subsp. 
zooepidemicus MGCS10565) 
Sez_0752(e-value: 4e-07) 
467_0 polysaccharide deacetylase family protein(Streptococcus 
pyogenes MGAS2096) 
MGAS2096_Spy1182(e-
value: 4e-35) 
471_2 tRNA-dihydrouridine synthase(Acinetobacter baumannii 
ACICU) 
ACICU_00749(e-value: 1e-
16) 
484_1 protein of unknown function DUF74(Leptotrichia buccalis 
C-1013-b) 
Lebu_1999(e-value: 2e-
51) 
496_0 hypothetical protein(Caldicellulosiruptor saccharolyticus 
DSM 8903) 
Csac_2063(e-value: 4e-08) 
497_0 polar amino acid ABC transporter, inner membrane 
subunit(Leptotrichia buccalis C-1013-b) 
Lebu_1162(e-value: 4e-
115) 
510_1 general secretion pathway protein F(Methylococcus 
capsulatus str. Bath) 
xpsF(e-value: 1e-40) 
522_2 GTP-binding protein TypA(Rickettsia bellii RML369-C) RBE_0285(e-value: 6e-37) 
528_0 protein of unknown function DUF1275(Leptotrichia 
buccalis C-1013-b) 
Lebu_0162(e-value: 1e-
98) 
555_1 hypothetical protein(Cellvibrio japonicus Ueda107) CJA_2591(e-value: 2e-15) 
558_1 putative protease HtpX(Tropheryma whipplei str. Twist) TWT013(e-value: 3e-82) 
574_0 hypothetical protein(Methylacidiphilum infernorum V4) Minf_1845(e-value: 6e-
10) 
574_1 Holliday junction DNA helicase RuvB(Vibrio vulnificus 
CMCP6) 
VV1_2161(e-value: 3e-25) 
594_0 glycosyl transferase, group 1(Acidithiobacillus 
ferrooxidans ATCC 53993) 
Lferr_0086(e-value: 3e-
08) 
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603_0 glutamine amidotransferase class-I(Leptotrichia buccalis 
C-1013-b) 
Lebu_1909(e-value: 6e-
97) 
604_0 hypothetical protein(Roseiflexus sp. RS-1) RoseRS_3685(e-value: 1e-
10) 
634_0 metalloendopeptidase(Bifidobacterium animalis subsp. 
lactis AD011) 
BLA_1066(e-value: 3e-06) 
636_1 transcriptional regulator(Bacillus clausii KSM-K16) ABC3138(e-value: 1e-25) 
646_0 similar to hemolysin-like(Bacillus licheniformis ATCC 
14580) 
yrkA2(e-value: 2e-15) 
666_1 putative cytoplasmic protein(Geobacillus 
thermodenitrificans NG80-2) 
GTNG_3408(e-value: 6e-
16) 
669_0 phosphotransacetylase(Helicobacter pylori HPAG1) HPAG1_0885(e-value: 2e-
32) 
681_0 hypothetical protein(Staphylococcus carnosus subsp. 
carnosus TM300) 
Sca_1875(e-value: 7e-18) 
681_1 EmrB/QacA family drug resistance transporter(Bacillus 
cereus ATCC 10987) 
BCE_2916(e-value: 3e-45) 
699_1 trans-sulfuration enzyme family protein(Chlorobium 
tepidum TLS) 
CT0703(e-value: 1e-10) 
712_0 phosphoglucomutase(Deinococcus radiodurans R1) pgm(e-value: 2e-07) 
712_1 penicillin-binding protein 1A(Staphylococcus aureus 
RF122) 
SAB1588(e-value: 3e-22) 
717_1 Glycoside hydrolase family 57(Thermotoga neapolitana 
DSM 4359) 
CTN_1055(e-value: 2e-32) 
728_0 PEBP family protein(Geobacter uraniireducens Rf4) Gura_1648(e-value: 5e-
27) 
734_2 putative nitrogen regulatory IIA protein (enzyme IIA-ntr) 
(phosphotransferase enzyme II, A 
component)(Candidatus Protochlamydia amoebophila 
UWE25) 
ptsN(e-value: 2e-06) 
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748_9 RNA polymerase sigma-G factor(Clostridium tetani E88) CTC01128(e-value: 3e-07) 
755_1 mannose-1-phosphate guanylyltransferase(Rickettsia 
bellii RML369-C) 
RBE_0245(e-value: 7e-08) 
793_0 single-strand binding protein(Leptotrichia buccalis C-
1013-b) 
Lebu_0211(e-value: 4e-
54) 
802_0 Tyrosyl-tRNA synthetase  (Geobacillus 
stearothermophilus) 
tyrS(e-value: 6e-64) 
814_2 elongation factor Ts(Thermus thermophilus HB27) tsf(e-value: 2e-42) 
814_4 30S ribosomal protein S2(Acinetobacter baumannii ATCC 
17978) 
A1S_2323(e-value: 1e-16) 
828_0 narrowly conserved hypothetical protein(Bifidobacterium 
longum subsp. infantis ATCC 15697) 
Blon_1036(e-value: 1e-17) 
831_0 ribonuclease P protein component(Leptotrichia buccalis 
C-1013-b) 
Lebu_2305(e-value: 2e-
45) 
836_4 holliday junction DNA helicase motor 
protein(Haemophilus parasuis SH0165) 
ruvA(e-value: 3e-13) 
843_0 Rossmann fold nucleotide-binding protein involved in 
DNA uptake(Streptococcus suis 05ZYH33) 
SSU05_0987(e-value: 8e-
16) 
851_0 transcriptional regulator(Streptococcus suis 05ZYH33) SSU05_2193(e-value: 2e-
23) 
851_1 Signal peptidase I(Prochlorococcus marinus str. MIT 
9515) 
P9515_05771(e-value: 8e-
08) 
852_0 truncated resolvase(Staphylococcus aureus subsp. aureus 
Mu50) 
truncated-res(e-value: 2e-
13) 
855_0 hypothetical protein(Leifsonia xyli subsp. xyli str. CTCB07) Lxx01200(e-value: 4e-74) 
861_1 ribosomal protein L31(Catenulispora acidiphila DSM 
44928) 
Caci_4370(e-value: 8e-23) 
867_0 ammonium transporter(Renibacterium salmoninarum 
ATCC 33209) 
RSal33209_1070(e-value: 
2e-08) 
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903_1 OmpA/MotB domain protein(Leptotrichia buccalis C-
1013-b) 
Lebu_1720(e-value: 8e-
23) 
905_0 excinuclease ABC subunit A(Erythrobacter litoralis 
HTCC2594) 
ELI_07895(e-value: 8e-06) 
941_0 H+transporting two-sector ATPase E subunit(Leptotrichia 
buccalis C-1013-b) 
Lebu_0755(e-value: 8e-
86) 
945_0 Spo0B-associated GTP-binding protein(Lysinibacillus 
sphaericus C3-41) 
Bsph_3946(e-value: 5e-
50) 
954_0 cytidine deaminase(Leptotrichia buccalis C-1013-b) Lebu_0864(e-value: 4e-
64) 
964_0 Probable deoxyribose-phosphate aldolase(Thermococcus 
sibiricus MM 739) 
TSIB_1148(e-value: 1e-53) 
980_0 hemolysin activator protein precursor(Fusobacterium 
nucleatum subsp. nucleatum ATCC 25586) 
FN0293(e-value: 8e-10) 
1072_0 Putative AAA+ superfamily ATPase(Bifidobacterium 
longum DJO10A) 
BLD_0142(e-value: 9e-19) 
1090_1 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_1795(e-value: 1e-
44) 
1092_2 uroporphyrinogen III synthase 
(hemD)(Methanocaldococcus jannaschii DSM 2661) 
MJ0994(e-value: 1e-13) 
1092_3 uroporphyrinogen-III C-methyltransferase(Lysinibacillus 
sphaericus C3-41) 
Bsph_3433(e-value: 2e-
15) 
1095_0 hypothetical protein(Streptococcus equi subsp. 
zooepidemicus MGCS10565) 
Sez_1955(e-value: 9e-09) 
1138_2 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_1783(e-value: 4e-
45) 
1141_0 branched-chain amino acid transport protein(Bacillus 
cereus E33L) 
azlC(e-value: 1e-13) 
1187_4 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_1940(e-value: 7e-
65) 
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1285_1 PTS system, mannose-specific IIAB 
component(Streptococcus pyogenes MGAS2096) 
MGAS2096_Spy1506(e-
value: 2e-33) 
1306_0 riboflavin kinase(Bacillus cereus 03BB102) BCA_2148(e-value: 5e-17) 
1319_0 NUDIX hydrolase(Pyrobaculum arsenaticum DSM 13514) Pars_2356(e-value: 5e-08) 
1323_8 heat shock protein Hsp20(Sulfurihydrogenibium sp. 
YO3AOP1) 
SYO3AOP1_1159(e-value: 
5e-13) 
1323_9 phosphoribosyltransferase(Candidatus Solibacter usitatus 
Ellin6076) 
Acid_3419(e-value: 1e-12) 
1365_3 ribosomal protein L33(Leptotrichia buccalis C-1013-b) Lebu_1899(e-value: 2e-
21) 
1426_1 Dihydrolipoyllysine-residue 
succinyltransferase(Leptotrichia buccalis C-1013-b) 
Lebu_0543(e-value: 3e-
140) 
1468_2 putative metal dependent 
phosphohydrolase(Leptotrichia buccalis C-1013-b) 
Lebu_1403(e-value: 1e-
49) 
1473_5 hypothetical protein(Listeria monocytogenes EGD-e) lmo2078(e-value: 7e-21) 
1531_0 50S ribosomal protein l14(Heliobacterium 
modesticaldum Ice1) 
rplN(e-value: 2e-43) 
1561_4 TfoX domain protein(Leptotrichia buccalis C-1013-b) Lebu_1291(e-value: 3e-
52) 
1604_0 phosphoribosyl-ATP pyrophosphatase(Lactobacillus 
fermentum IFO 3956) 
hisE(e-value: 3e-25) 
1616_0 30S ribosomal protein S8(Pelobacter propionicus DSM 
2379) 
rpsH(e-value: 3e-26) 
1619_1 hypothetical protein(Staphylococcus saprophyticus 
subsp. saprophyticus ATCC 15305) 
SSP0469(e-value: 1e-07) 
1634_0 ABC type periplasmic choline/glycine/betaine binding 
protein(Yersinia pestis Nepal516) 
YPN_2780(e-value: 8e-08) 
1640_1 ribosomal protein L15(Coprothermobacter proteolyticus 
DSM 5265) 
rplO(e-value: 1e-19) 
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1646_0 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_1518(e-value: 5e-
113) 
1674_0 MarR family transcriptional regulator(Streptococcus 
agalactiae A909) 
SAK_1868(e-value: 9e-39) 
1685_0 hypothetical protein(Macrococcus caseolyticus 
JCSC5402) 
MCCL_1596(e-value: 9e-
24) 
1695_0 hypothetical protein(Yersinia pestis Nepal516) YPN_2781(e-value: 5e-11) 
1707_0 sodium-glutamate/aspartate symporter(Bacillus 
halodurans C-125) 
BH3227(e-value: 5e-10) 
1710_1 membrane protein of unknown function(Delftia 
acidovorans SPH-1) 
Daci_0859(e-value: 2e-08) 
1713_1 50S ribosomal protein L5(Psychrobacter sp. PRwf-1) rplE(e-value: 6e-44) 
1717_2 mannose-1-phosphate guanylyltransferase, 
putative(Clostridium novyi NT) 
NT01CX_0602(e-value: 
3e-12) 
1718_0 NUDIX hydrolase(Novosphingobium aromaticivorans 
DSM 12444) 
Saro_2655(e-value: 3e-06) 
1728_0 hypothetical protein(Bacillus cereus ATCC 10987) BCE_4466(e-value: 1e-13) 
1729_0 hypothetical protein(Actinobacillus pleuropneumoniae 
serovar 7 str. AP76) 
APP7_0688(e-value: 1e-
15) 
1735_0 50S ribosomal protein L6(Bradyrhizobium sp. BTAi1) rplF(e-value: 8e-40) 
1736_0 phenazine biosynthesis protein PhzF family(Akkermansia 
muciniphila ATCC BAA-835) 
Amuc_0023(e-value: 8e-
81) 
1740_0 hypothetical protein(Methanosphaera stadtmanae DSM 
3091) 
Msp_0734(e-value: 2e-20) 
1754_1 Protein of unknown function DUF214(Brucella abortus 
S19) 
BAbS19_I15750(e-value: 
3e-22) 
1754_3 putative ABC transporter, ATP-binding 
protein(Streptococcus mutans UA159) 
SMU.863(e-value: 8e-68) 
1760_0 ribosome-binding factor A(Leptotrichia buccalis C-1013- Lebu_1316(e-value: 3e-
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b) 58) 
1766_1 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_1144(e-value: 1e-
39) 
1769_1 30S ribosomal protein S10(Lactobacillus reuteri JCM 
1112) 
LAR_1395(e-value: 1e-31) 
1773_0 lipid A biosynthesis acyltransferase(Leptotrichia buccalis 
C-1013-b) 
Lebu_0285(e-value: 1e-
143) 
1776_2 UDP-N-acetylmuramate--L-alanine ligase(Burkholderia 
cenocepacia MC0-3) 
murC(e-value: 5e-44) 
1777_1 malate dehydrogenase(Lactobacillus rhamnosus GG) LGG_02876(e-value: 2e-
27) 
1778_1 hypothetical protein(Leptotrichia buccalis C-1013-b) Lebu_0532(e-value: 1e-
36) 
1780_0 D-tyrosyl-tRNA(Tyr) deacylase(Leptotrichia buccalis C-
1013-b) 
Lebu_0701(e-value: 2e-
55) 
1783_1 hypothetical protein(Chlamydophila pneumoniae J138) CPj0340(e-value: 2e-09) 
1784_1 hypothetical protein(Porphyromonas gingivalis ATCC 
33277) 
PGN_0382(e-value: 5e-21) 
1788_1 small GTP-binding protein(Leptotrichia buccalis C-1013-b) Lebu_1928(e-value: 1e-
85) 
1798_0 Type IV pili nucleotide-binding protein(Francisella 
tularensis subsp. holarctica) 
FTL_1770(e-value: 2e-53) 
1800_1 ParA family ATPase(Symbiobacterium thermophilum IAM 
14863) 
STH3333(e-value: 2e-76) 
1801_0 single-stranded-DNA-specific exonuclease(Streptococcus 
pyogenes MGAS9429) 
MGAS9429_Spy0784(e-
value: 5e-43) 
1804_1 recombinase(Fusobacterium nucleatum subsp. 
polymorphum ATCC 10953) 
FNP_pFN3g09(e-value: 
2e-26) 
1805_1 hypothetical protein(Flavobacterium psychrophilum 
JIP02/86) 
FP0837(e-value: 3e-35) 
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1811_1 ribosomal protein S9(Petrotoga mobilis SJ95) Pmob_0800(e-value: 2e-
31) 
1812_0 ribonucleotide-diphosphate reductase subunit 
beta(Candidatus Liberibacter asiaticus str. psy62) 
CLIBASIA_00075(e-value: 
4e-16) 
1813_0 phosphotransferase system IIC component, 
glucose/maltose/N-acetylglucosamine-
specific(Streptococcus suis 98HAH33) 
SSU98_1936(e-value: 2e-
68) 
1814_0 dihydrolipoamide dehydrogenase(Desulfotomaculum 
reducens MI-1) 
Dred_2832(e-value: 5e-
36) 
1821_11 hypothetical protein(Clostridium kluyveri NBRC 12016) CKR_1146(e-value: 5e-09) 
1828_4 phage protein(Flavobacterium psychrophilum JIP02/86) FP2178(e-value: 1e-12) 
1829_0 5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase(Lysinibacillus sphaericus C3-41) 
Bsph_2979(e-value: 9e-
65) 
1833_0 rRNA methylase(Micrococcus luteus NCTC 2665) Mlut_02030(e-value: 1e-
54) 
1842_0 ABC-type polysaccharide/polyol phosphate transport 
system, ATPase component(Streptococcus suis 98HAH33) 
SSU98_1301(e-value: 9e-
86) 
1842_1 ABC-type polysaccharide/polyol phosphate export 
system, permease component(Streptococcus suis 
98HAH33) 
SSU98_1302(e-value: 9e-
66) 
1843_0 FolD bifunctional protein(Thermodesulfovibrio 
yellowstonii DSM 11347) 
THEYE_A0674(e-value: 1e-
33) 
1844_0 CTP synthase(Mycoplasma mycoides subsp. mycoides SC 
str. PG1) 
pyrG(e-value: 3e-40) 
1844_1 large conductance mechanosensitive channel 
protein(Dyadobacter fermentans DSM 18053) 
Dfer_3491(e-value: 4e-06) 
1845_1 chaperonin Hsp40(uncultured methanogenic archaeon 
RC-I) 
dnaJ(e-value: 7e-51) 
1850_1 hypothetical protein(Thermobifida fusca YX) Tfu_0647(e-value: 4e-24) 
1850_2 hypothetical protein(Corynebacterium aurimucosum cauri_2344(e-value: 1e-
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ATCC 700975) 24) 
1853_1 ribosomal protein S4(Chloroflexus sp. Y-400-fl) Chy400_2582(e-value: 3e-
48) 
1853_4 ribosomal protein L17(Nautilia profundicola AmH) rplQ(e-value: 4e-28) 
1889_2 ybaK/ebsC protein(Leptotrichia buccalis C-1013-b) Lebu_0669(e-value: 8e-
71) 
1968_2 ABC transporter, permease; probable glutamine ABC 
transporter, permease(Bacillus cereus Q1) 
glnP(e-value: 1e-17) 
2054_1 glycosyl transferase, group 1(Acaryochloris marina 
MBIC11017) 
AM1_2714(e-value: 7e-
13) 
2133_1 protein of unknown function DUF45(Prosthecochloris 
aestuarii DSM 271) 
Paes_0312(e-value: 1e-
09) 
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APPENDIX D 
EC GeneId Vote 
1.1.1.37 4191 20 
1.1.1.39 4199 20 
1.1.1.39 10873 20 
1.1.1.40 4199 20 
1.1.1.40 10873 20 
1.1.1.81 1487 20 
1.1.1.81 9380 20 
1.1.1.88 3156 20 
1.1.1.100 622 20 
1.1.1.100 3028 20 
1.1.1.100 3292 20 
1.1.1.100 3294 20 
1.1.1.100 7923 20 
1.1.1.100 8630 20 
1.1.1.100 51170 20 
1.1.1.100 54995 20 
1.1.1.100 83693 20 
1.1.1.100 84263 20 
1.1.1.100 157506 20 
1.2.1.8 216 20 
1.2.1.8 218 20 
1.2.1.8 219 20 
1.2.1.8 223 20 
1.2.1.8 7915 20 
1.2.1.8 8659 20 
1.2.1.8 8854 20 
1.2.1.19 218 20 
1.2.1.19 8659 20 
1.2.1.27 216 20 
1.2.1.27 218 20 
1.2.1.27 220 20 
1.2.1.27 223 20 
1.2.1.27 224 20 
1.2.1.27 501 20 
1.2.1.27 7915 20 
1.2.1.27 8659 20 
1.2.1.27 8854 20 
1.2.1.27 64577 20 
1.3.98.1 1806 20 
1.3.99.1 6389 20 
1.3.99.1 6390 20 
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1.4.1.2 2746 20 
1.4.1.2 2747 20 
1.4.1.4 2746 20 
1.4.1.4 2747 20 
1.4.3.2 196743 20 
1.13.11.12 239 20 
1.13.11.12 240 20 
1.13.11.12 246 20 
2.1.1.13 23743 20 
2.1.1.33 4234 20 
2.1.1.56 8731 20 
2.1.1.71 10400 20 
2.1.1.100 23463 20 
2.3.1.29 2805 20 
2.3.1.29 2806 20 
2.3.1.29 2875 20 
2.3.1.29 6898 20 
2.3.1.29 51166 20 
2.3.1.29 84706 20 
2.3.1.39 55301 20 
2.3.1.68 219970 20 
2.3.1.76 6646 20 
2.3.1.76 8435 20 
2.3.1.76 8694 20 
2.3.1.76 80168 20 
2.3.1.76 84649 20 
2.3.1.76 116255 20 
2.3.1.76 158833 20 
2.3.1.76 158835 20 
2.3.1.76 346606 20 
2.3.1.86 27349 20 
2.3.1.86 54995 20 
2.3.1.192 219970 20 
2.4.1.22 2683 20 
2.4.1.22 8702 20 
2.4.1.22 8703 20 
2.4.1.22 8704 20 
2.4.1.22 9331 20 
2.4.1.22 9334 20 
2.4.1.22 11285 20 
2.4.1.22 51809 20 
2.4.1.22 57452 20 
2.4.1.22 63917 20 
2.4.1.22 79623 20 
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2.4.1.87 28 20 
2.4.1.144 4248 20 
2.4.1.150 2651 20 
2.4.1.150 9245 20 
2.4.1.150 51301 20 
2.4.1.150 64132 20 
2.4.1.150 140687 20 
2.4.2.14 2673 20 
2.4.2.14 9945 20 
2.4.99.6 6480 20 
2.4.99.6 6483 20 
2.4.99.6 6484 20 
2.4.99.6 6487 20 
2.4.99.6 7903 20 
2.4.99.6 8128 20 
2.4.99.6 8869 20 
2.4.99.6 10402 20 
2.4.99.6 10610 20 
2.4.99.6 30815 20 
2.4.99.6 51046 20 
2.4.99.6 55808 20 
2.4.99.6 81849 20 
2.4.99.6 256435 20 
2.6.1.1 211 20 
2.6.1.1 212 20 
2.6.1.1 883 20 
2.6.1.1 2875 20 
2.6.1.1 6898 20 
2.6.1.1 51166 20 
2.6.1.1 84706 20 
2.6.1.1 137362 20 
2.7.1.76 1633 20 
2.7.1.76 1716 20 
2.7.1.76 7084 20 
2.7.1.94 64781 20 
2.7.1.108 1040 20 
2.7.1.108 8760 20 
2.7.1.140 3706 20 
2.7.1.140 3707 20 
2.7.1.140 9807 20 
2.7.1.140 51447 20 
2.7.1.140 80271 20 
2.7.1.140 117283 20 
2.7.1.140 253430 20 
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2.7.7.9 29926 20 
2.7.7.23 29926 20 
2.8.2.23 3340 20 
2.8.2.23 4166 20 
2.8.2.23 6817 20 
2.8.2.23 6819 20 
2.8.2.23 6820 20 
2.8.2.23 6822 20 
2.8.2.23 8534 20 
2.8.2.23 9435 20 
2.8.2.23 9469 20 
2.8.2.23 9957 20 
2.8.2.23 10164 20 
2.8.2.23 25830 20 
2.8.2.23 27233 20 
2.8.2.23 27284 20 
2.8.2.23 56548 20 
2.8.2.30 3340 20 
2.8.2.30 4166 20 
3.1.1.3 43 20 
3.1.1.3 590 20 
3.1.1.3 1056 20 
3.1.1.3 1066 20 
3.1.1.3 3990 20 
3.1.1.3 3991 20 
3.1.1.3 4023 20 
3.1.1.3 5407 20 
3.1.1.3 5408 20 
3.1.1.3 22871 20 
3.1.1.3 54413 20 
3.1.1.3 57555 20 
3.1.1.3 200879 20 
3.1.1.3 283848 20 
3.1.3.3 5723 20 
3.1.4.38 5167 20 
3.1.4.38 5169 20 
3.2.1.31 4126 20 
3.4.19.14 2678 20 
3.4.19.14 2687 20 
3.4.19.14 91227 20 
3.4.19.14 92086 20 
3.5.1.1 175 20 
3.5.4.2 161823 20 
3.5.4.6 161823 20 
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3.5.4.14 339 20 
3.5.4.14 9582 20 
3.5.4.14 10930 20 
3.5.4.14 140564 20 
3.6.1.15 953 20 
3.6.1.15 954 20 
3.6.1.15 955 20 
3.6.1.15 956 20 
3.6.1.15 957 20 
3.6.1.22 4521 20 
3.6.1.22 53343 20 
3.6.1.22 167227 20 
3.6.1.42 953 20 
3.6.1.42 954 20 
3.6.1.42 955 20 
3.6.1.42 956 20 
3.6.1.42 957 20 
3.6.1.43 130367 20 
3.6.3.9 476 20 
3.6.3.9 479 20 
3.6.3.9 480 20 
3.6.3.9 488 20 
3.6.3.9 5205 20 
3.6.3.9 10079 20 
3.6.3.9 10396 20 
3.6.3.9 23120 20 
3.6.3.9 23200 20 
3.6.3.9 23250 20 
3.6.3.9 51761 20 
3.6.3.9 57130 20 
3.6.3.9 57194 20 
3.6.3.9 84239 20 
3.6.3.9 344905 20 
3.6.3.9 374868 20 
3.7.1.2 51011 20 
3.7.1.2 151313 20 
5.1.3.8 5973 20 
5.4.2.2 283209 20 
6.1.1.5 51520 20 
6.1.1.5 57176 20 
6.1.1.16 833 20 
6.1.1.19 55152 20 
6.2.1.5 8801 20 
6.3.2.6 10606 20 
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1.1.1.100 27349 19 
1.2.1.8 220 19 
1.2.1.19 223 19 
1.2.1.19 7915 19 
2.3.1.29 883 19 
2.4.99.6 29906 19 
2.4.99.6 84620 19 
2.6.1.2 211 19 
2.6.1.2 212 19 
2.6.1.2 84706 19 
2.8.2.23 222537 19 
2.8.2.30 6817 19 
3.6.1.15 2074 19 
6.2.1.2 28965 19 
6.2.1.5 47 19 
1.2.1.8 224 18 
1.2.1.19 224 18 
1.2.1.27 217 18 
1.2.1.27 219 18 
2.4.99.6 6482 18 
2.8.2.23 6783 18 
3.4.19.14 2686 18 
3.5.4.14 57379 18 
3.6.1.15 56916 18 
3.6.3.9 487 18 
3.6.3.20 20 18 
6.2.1.4 47 18 
2.6.1.2 883 17 
3.6.1.15 1974 17 
3.6.1.15 6596 17 
3.6.1.15 50485 17 
5.4.2.2 5238 17 
5.4.2.2 55276 17 
6.1.1.5 7407 17 
6.2.1.5 8803 17 
2.4.99.6 338596 16 
2.6.1.2 137362 16 
2.7.7.23 8893 16 
3.6.1.15 546 16 
3.6.1.15 9775 16 
3.6.1.15 57697 16 
6.2.1.2 10998 16 
1.2.1.8 217 15 
3.6.1.15 3070 15 
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3.6.1.15 375748 15 
6.2.1.2 11000 15 
1.13.11.12 247 14 
2.4.99.6 27090 14 
2.8.2.30 9957 14 
3.1.1.3 8513 14 
3.6.1.15 60625 14 
3.6.3.9 489 14 
1.2.1.8 4329 13 
2.7.1.15 132 13 
3.6.3.9 9914 13 
3.6.3.20 19 13 
3.6.3.20 23 13 
6.3.5.5 32 13 
3.6.1.15 9704 12 
3.6.1.15 25788 12 
3.6.1.15 51202 12 
3.6.3.20 24 12 
6.2.1.2 6296 12 
1.2.1.27 10840 11 
2.3.1.29 211 11 
2.8.2.30 9469 11 
2.8.2.30 222537 11 
3.1.1.3 5406 11 
3.6.1.15 1106 11 
3.6.1.15 1973 11 
3.6.1.15 79009 11 
3.6.3.9 27032 11 
6.2.1.2 54988 11 
1.13.11.12 242 10 
2.3.1.39 54995 10 
2.8.2.30 27284 10 
3.6.1.15 10721 10 
3.6.1.15 11269 10 
3.6.1.15 84181 10 
3.6.3.9 495 10 
3.6.3.14 523 10 
1.2.1.13 2597 9 
1.2.1.13 26330 9 
3.6.1.15 8458 9 
2.3.1.61 31 8 
2.3.1.61 32 8 
2.8.2.30 8534 8 
3.6.1.15 55636 8 
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3.6.1.15 80205 8 
3.6.3.9 478 8 
6.2.1.2 123876 8 
2.3.1.29 212 7 
3.1.3.67 5728 7 
3.6.1.15 7919 7 
3.6.1.15 57680 7 
3.6.3.9 477 7 
3.6.3.20 1080 7 
6.1.1.3 11232 7 
6.1.1.15 11232 7 
6.3.5.2 1373 7 
1.2.1.19 8854 6 
2.7.1.94 1608 6 
2.8.2.30 9435 6 
3.2.1.46 2581 6 
3.6.1.15 56919 6 
3.6.3.20 55324 6 
2.3.1.86 2194 5 
2.7.1.94 1607 5 
2.7.1.94 8526 5 
2.8.2.30 10164 5 
3.6.1.15 55510 5 
3.6.3.20 10061 5 
6.3.5.5 1503 5 
1.2.1.27 4329 4 
2.3.1.61 1629 4 
2.6.1.2 2875 4 
2.8.2.23 6818 4 
3.5.4.12 1635 4 
3.6.3.9 490 4 
3.6.3.9 493 4 
1.2.4.4 55526 3 
3.6.1.15 1105 3 
3.6.1.15 9557 3 
3.6.1.15 9879 3 
3.6.3.9 492 3 
6.3.5.5 5091 3 
1.2.1.19 216 2 
2.1.1.10 4548 2 
2.6.1.2 2806 2 
2.7.1.94 1606 2 
2.7.1.94 56848 2 
2.7.7.9 7360 2 
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2.7.7.23 7360 2 
2.8.2.30 6818 2 
3.6.1.15 22907 2 
3.6.1.15 79665 2 
3.6.3.9 491 2 
6.1.1.19 5917 2 
1.1.1.100 3295 1 
1.2.1.19 220 1 
2.3.1.61 8050 1 
2.6.1.2 2805 1 
2.6.1.5 6898 1 
2.7.1.94 9162 1 
2.7.1.94 139189 1 
2.8.2.30 6819 1 
2.8.2.30 25830 1 
3.6.1.15 23020 1 
3.6.1.15 54505 1 
3.6.1.15 55308 1 
3.6.1.15 55794 1 
3.6.3.20 6891 1 
5.3.1.8 4351 1 
6.2.1.2 81616 1 
6.3.5.2 8833 1 
6.3.5.5 56474 1 
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APPENDIX E 
Orphan 
Enzyme 
(EC) 
Candidate 
(NCBI 
EntrezGeneId) 
Official 
Symbol Official Full Name 
1.1.1.100  157506 RDH10 retinol dehydrogenase 10 (all-trans) 
1.1.1.100  3028 HSD17B10 hydroxysteroid (17-beta) dehydrogenase 10 
1.1.1.100  3292 HSD17B1 hydroxysteroid (17-beta) dehydrogenase 1 
1.1.1.100  3294 HSD17B2 hydroxysteroid (17-beta) dehydrogenase 2 
1.1.1.100  51170 HSD17B11 hydroxysteroid (17-beta) dehydrogenase 11 
1.1.1.100  54995 OXSM 3-oxoacyl-ACP synthase, mitochondrial 
1.1.1.100  622 BDH1 3-hydroxybutyrate dehydrogenase, type 1 
1.1.1.100  7923 HSD17B8 hydroxysteroid (17-beta) dehydrogenase 8 
1.1.1.100  83693 HSDL1 hydroxysteroid dehydrogenase like 1 
1.1.1.100  84263 HSDL2 hydroxysteroid dehydrogenase like 2 
1.1.1.100  8630 HSD17B6 hydroxysteroid (17-beta) dehydrogenase 6 
1.1.1.100  27349 MCAT 
malonyl CoA:ACP acyltransferase 
(mitochondrial) 
1.1.1.100  3295 HSD17B4 hydroxysteroid (17-beta) dehydrogenase 4 
1.1.1.39  10873 ME3 
malic enzyme 3, NADP(+)-dependent, 
mitochondrial 
1.1.1.39  4199 ME1 malic enzyme 1, NADP(+)-dependent, cytosolic 
1.1.1.88  3156 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase 
1.13.11.12  239 ALOX12 arachidonate 12-lipoxygenase 
1.13.11.12  240 ALOX5 arachidonate 5-lipoxygenase 
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1.13.11.12  246 ALOX15 arachidonate 15-lipoxygenase 
1.13.11.12  247 ALOX15B arachidonate 15-lipoxygenase, type B 
1.13.11.12  242 ALOX12B arachidonate 12-lipoxygenase, 12R type 
1.2.1.13  2597 GAPDH glyceraldehyde-3-phosphate dehydrogenase 
1.2.1.13  26330 GAPDHS 
glyceraldehyde-3-phosphate dehydrogenase, 
spermatogenic 
1.2.1.19  218 ALDH3A1 aldehyde dehydrogenase 3 family, member A1 
1.2.1.19  8659 ALDH4A1 aldehyde dehydrogenase 4 family, member A1 
1.2.1.19  223 ALDH9A1 aldehyde dehydrogenase 9 family, member A1 
1.2.1.19  7915 ALDH5A1 aldehyde dehydrogenase 5 family, member A1 
1.2.1.19  224 ALDH3A2 aldehyde dehydrogenase 3 family, member A2 
1.2.1.19  8854 ALDH1A2 aldehyde dehydrogenase 1 family, member A2 
1.2.1.19  216 ALDH1A1 aldehyde dehydrogenase 1 family, member A1 
1.2.1.19  220 ALDH1A3 aldehyde dehydrogenase 1 family, member A3 
1.2.1.8  216 ALDH1A1 aldehyde dehydrogenase 1 family, member A1 
1.2.1.8  218 ALDH3A1 aldehyde dehydrogenase 3 family, member A1 
1.2.1.8  219 ALDH1B1 aldehyde dehydrogenase 1 family, member B1 
1.2.1.8  223 ALDH9A1 aldehyde dehydrogenase 9 family, member A1 
1.2.1.8  7915 ALDH5A1 aldehyde dehydrogenase 5 family, member A1 
1.2.1.8  8659 ALDH4A1 aldehyde dehydrogenase 4 family, member A1 
1.2.1.8  8854 ALDH1A2 aldehyde dehydrogenase 1 family, member A2 
1.2.1.8  220 ALDH1A3 aldehyde dehydrogenase 1 family, member A3 
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1.2.1.8  224 ALDH3A2 aldehyde dehydrogenase 3 family, member A2 
1.2.1.8  217 ALDH2 
aldehyde dehydrogenase 2 family 
(mitochondrial) 
1.2.1.8  4329 ALDH6A1 aldehyde dehydrogenase 6 family, member A1 
1.3.98.1  1806 DPYD dihydropyrimidine dehydrogenase 
1.3.99.1  6389 SDHA 
succinate dehydrogenase complex, subunit A, 
flavoprotein (Fp) 
1.3.99.1  6390 SDHB 
succinate dehydrogenase complex, subunit B, 
iron sulfur (Ip) 
1.4.1.2  2746 GLUD1 glutamate dehydrogenase 1 
1.4.1.2  2747 GLUD2 glutamate dehydrogenase 2 
1.4.1.4  2746 GLUD1 glutamate dehydrogenase 1 
1.4.1.4  2747 GLUD2 glutamate dehydrogenase 2 
1.4.3.2  196743 PAOX polyamine oxidase (exo-N4-amino) 
2.1.1.10  4548 MTR 
5-methyltetrahydrofolate-homocysteine 
methyltransferase 
2.1.1.71  10400 PEMT phosphatidylethanolamine N-methyltransferase 
2.3.1.192  219970 GLYATL2 glycine-N-acyltransferase-like 2 
2.3.1.68  219970 GLYATL2 glycine-N-acyltransferase-like 2 
2.3.1.86  27349 MCAT 
malonyl CoA:ACP acyltransferase 
(mitochondrial) 
2.3.1.86  54995 OXSM 3-oxoacyl-ACP synthase, mitochondrial 
2.3.1.86  2194 FASN fatty acid synthase 
2.4.1.87  28 ABO 
ABO blood group (transferase A, alpha 1-3-N-
acetylgalactosaminyltransferase; transferase B, 
alpha 1-3-galactosyltransferase) 
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2.7.1.140  117283 IP6K3 inositol hexakisphosphate kinase 3 
2.7.1.140  253430 IPMK inositol polyphosphate multikinase 
2.7.1.140  3706 ITPKA inositol-trisphosphate 3-kinase A 
2.7.1.140  3707 ITPKB inositol-trisphosphate 3-kinase B 
2.7.1.140  51447 IP6K2 inositol hexakisphosphate kinase 2 
2.7.1.140  80271 ITPKC inositol-trisphosphate 3-kinase C 
2.7.1.140  9807 IP6K1 inositol hexakisphosphate kinase 1 
2.7.1.76  1633 DCK deoxycytidine kinase 
2.7.1.76  1716 DGUOK deoxyguanosine kinase 
2.7.1.76  7084 TK2 thymidine kinase 2, mitochondrial 
2.7.7.23  29926 GMPPA GDP-mannose pyrophosphorylase A 
2.7.7.23  8893 EIF2B5 
eukaryotic translation initiation factor 2B, 
subunit 5 epsilon, 82kDa 
2.7.7.23  7360 UGP2 UDP-glucose pyrophosphorylase 2 
2.8.2.30  3340 NDST1 
N-deacetylase/N-sulfotransferase (heparan 
glucosaminyl) 1 
2.8.2.30  4166 CHST6 
carbohydrate (N-acetylglucosamine 6-O) 
sulfotransferase 6 
2.8.2.30  6817 SULT1A1 
sulfotransferase family, cytosolic, 1A, phenol-
preferring, member 1 
2.8.2.30  9957 HS3ST1 
heparan sulfate (glucosamine) 3-O-
sulfotransferase 1 
2.8.2.30  222537 HS3ST5 
heparan sulfate (glucosamine) 3-O-
sulfotransferase 5 
2.8.2.30  9469 CHST3 carbohydrate (chondroitin 6) sulfotransferase 3 
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2.8.2.30  27284 SULT1B1 
sulfotransferase family, cytosolic, 1B, member 
1 
2.8.2.30  8534 CHST1 
carbohydrate (keratan sulfate Gal-6) 
sulfotransferase 1 
2.8.2.30  9435 
  2.8.2.30  10164 
  
2.8.2.30  6818 SULT1A3 
sulfotransferase family, cytosolic, 1A, phenol-
preferring, member 3 
2.8.2.30  25830 SULT4A1 sulfotransferase family 4A, member 1 
2.8.2.30  6819 SULT1C 
sulfotransferase family, cytosolic, 1C, member 
2 
3.1.4.38  5167 ENPP1 
ectonucleotide 
pyrophosphatase/phosphodiesterase 1 
3.1.4.38  5169 ENPP3 
ectonucleotide 
pyrophosphatase/phosphodiesterase 3 
3.4.19.14  2678 GGT1 gamma-glutamyltransferase 1 
3.4.19.14  2687 GGT5 gamma-glutamyltransferase 5 
3.4.19.14  91227 GGTLC2 gamma-glutamyltransferase light chain 2 
3.4.19.14  92086 GGTLC1 gamma-glutamyltransferase light chain 1 
3.4.19.14  2686 GGT7 gamma-glutamyltransferase 7 
3.5.4.14  10930 APOBEC2 
apolipoprotein B mRNA editing enzyme, 
catalytic polypeptide-like 2 
3.5.4.14  140564 
APOBEC3
D 
apolipoprotein B mRNA editing enzyme, 
catalytic polypeptide-like 3D 
3.5.4.14  339 APOBEC1 
apolipoprotein B mRNA editing enzyme, 
catalytic polypeptide 1 
3.5.4.14  9582 APOBEC3 apolipoprotein B mRNA editing enzyme, 
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B catalytic polypeptide-like 3B 
3.5.4.14  57379 AICDA activation-induced cytidine deaminase 
3.5.4.2  161823 ADAL adenosine deaminase-like 
3.5.4.6  161823 ADAL adenosine deaminase-like 
3.6.1.15  953 ENTPD1 
ectonucleoside triphosphate 
diphosphohydrolase 1 
3.6.1.15  954 ENTPD2 
ectonucleoside triphosphate 
diphosphohydrolase 2 
3.6.1.15  955 ENTPD6 
ectonucleoside triphosphate 
diphosphohydrolase 6 (putative) 
3.6.1.15  956 ENTPD3 
ectonucleoside triphosphate 
diphosphohydrolase 3 
3.6.1.15  957 ENTPD5 
ectonucleoside triphosphate 
diphosphohydrolase 5 
3.6.1.15  2074 ERCC6 excision repair cross-complementation group 6 
3.6.1.15  56916 
  3.6.1.15  1974 EIF4A2 eukaryotic translation initiation factor 4A2 
3.6.1.15  50485 SMARCAL1 
SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily a-
like 1 
3.6.1.15  6596 HLTF helicase-like transcription factor 
3.6.1.15  546 ATRX 
alpha thalassemia/mental retardation syndrome 
X-linked 
3.6.1.15  57697 FANCM Fanconi anemia, complementation group M 
3.6.1.15  9775 EIF4A3 eukaryotic translation initiation factor 4A3 
3.6.1.15  3070 HELLS helicase, lymphoid-specific 
3.6.1.15  375748 ERCC6L2 excision repair cross-complementation group 6-
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like 2 
3.6.1.15  60625 
  3.6.1.15  25788 RAD54B RAD54 homolog B (S. cerevisiae) 
3.6.1.15  51202 DDX47 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 
3.6.1.15  9704 DHX34 DEAH (Asp-Glu-Ala-His) box polypeptide 34 
3.6.1.15  1106 CHD2 chromodomain helicase DNA binding protein 2 
3.6.1.15  1973 EIF4A1 eukaryotic translation initiation factor 4A1 
3.6.1.15  79009 DDX50 DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 
3.6.1.15  10721 POLQ polymerase (DNA directed), theta 
3.6.1.15  11269 DDX19B DEAD (Asp-Glu-Ala-Asp) box polypeptide 19B 
3.6.1.15  84181 CHD6 chromodomain helicase DNA binding protein 6 
3.6.1.15  8458 TTF2 
transcription termination factor, RNA 
polymerase II 
3.6.1.15  55636 CHD7 chromodomain helicase DNA binding protein 7 
3.6.1.15  80205 CHD9 chromodomain helicase DNA binding protein 9 
3.6.1.15  57680 CHD8 chromodomain helicase DNA binding protein 8 
3.6.1.15  7919 DDX39B DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B 
3.6.1.15  56919 
  3.6.1.15  55510 
  3.6.1.15  1105 
  3.6.1.15  9557 
  3.6.1.15  9879 
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3.6.1.15  22907 DHX30 DEAH (Asp-Glu-Ala-His) box helicase 30 
3.6.1.15  79665 DHX40 DEAH (Asp-Glu-Ala-His) box polypeptide 40 
3.6.1.15  23020 SNRNP200 small nuclear ribonucleoprotein 200kDa (U5) 
3.6.1.15  54505 DHX29 DEAH (Asp-Glu-Ala-His) box polypeptide 29 
3.6.1.15  55308 DDX19A DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A 
3.6.1.15  55794 DDX28 DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 
3.6.1.22  167227 DCP2 decapping mRNA 2 
3.6.1.22  4521 NUDT 
nudix (nucleoside diphosphate linked moiety 
X)-type motif 1 
3.6.1.22  53343 NUDT9 
nudix (nucleoside diphosphate linked moiety 
X)-type motif 9 
3.6.1.42  953 ENTPD1 
ectonucleoside triphosphate 
diphosphohydrolase 1 
3.6.1.42  954 ENTPD2 
ectonucleoside triphosphate 
diphosphohydrolase 2 
3.6.1.42  955 ENTPD6 
ectonucleoside triphosphate 
diphosphohydrolase 6 (putative) 
3.6.1.42  956 ENTPD3 
ectonucleoside triphosphate 
diphosphohydrolase 3 
3.6.1.42  957 ENTPD5 
ectonucleoside triphosphate 
diphosphohydrolase 5 
3.6.1.43  130367 SGPP2 sphingosine-1-phosphate phosphatase 2 
3.6.3.20  20 ABCA2 
ATP-binding cassette, sub-family A (ABC1), 
member 2 
3.6.3.20  19 ABCA1 
ATP-binding cassette, sub-family A (ABC1), 
member 1 
3.6.3.20  23 ABCF1 
ATP-binding cassette, sub-family F (GCN20), 
member 1 
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3.6.3.20  24 ABCA4 
ATP-binding cassette, sub-family A (ABC1), 
member 4 
3.6.3.20  1080 CFTR 
cystic fibrosis transmembrane conductance 
regulator (ATP-binding cassette sub-family C, 
member 7) 
3.6.3.20  55324 ABCF3 
ATP-binding cassette, sub-family F (GCN20), 
member 3 
3.6.3.20  10061 ABCF2 
ATP-binding cassette, sub-family F (GCN20), 
member 2 
3.6.3.20  6891 TAP2 
transporter 2, ATP-binding cassette, sub-family 
B (MDR/TAP) 
3.7.1.2  151313 FAHD2B 
fumarylacetoacetate hydrolase domain 
containing 2B 
3.7.1.2  51011 FAHD2A 
fumarylacetoacetate hydrolase domain 
containing 2A 
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